Gene Symbol | Gene ID | Gene Info |
---|---|---|
Hsf2
|
ENSMUSG00000019878.7 | Hsf2 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
Hsf2 | chr10_57488530_57488725 | 2202 | 0.258431 | -0.41 | 1.1e-03 | Click! |
Hsf2 | chr10_57488830_57489020 | 2500 | 0.243542 | -0.30 | 2.1e-02 | Click! |
Hsf2 | chr10_57499477_57499901 | 685 | 0.682899 | 0.28 | 2.9e-02 | Click! |
Hsf2 | chr10_57489831_57489982 | 3481 | 0.214358 | -0.23 | 8.0e-02 | Click! |
Hsf2 | chr10_57490313_57490464 | 3963 | 0.206201 | -0.17 | 1.9e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr9_50752994_50754649 | 6.48 |
Cryab |
crystallin, alpha B |
574 |
0.54 |
chr14_63268302_63270010 | 6.35 |
Gata4 |
GATA binding protein 4 |
1968 |
0.31 |
chr9_79977295_79978179 | 6.34 |
Filip1 |
filamin A interacting protein 1 |
67 |
0.97 |
chr11_65268412_65269105 | 6.04 |
Myocd |
myocardin |
1096 |
0.55 |
chr10_58395820_58396456 | 5.84 |
Lims1 |
LIM and senescent cell antigen-like domains 1 |
1750 |
0.37 |
chr3_57293752_57294965 | 5.75 |
Tm4sf1 |
transmembrane 4 superfamily member 1 |
194 |
0.95 |
chr14_101886945_101887764 | 5.72 |
Lmo7 |
LIM domain only 7 |
3235 |
0.35 |
chrX_157701658_157702782 | 5.62 |
Smpx |
small muscle protein, X-linked |
378 |
0.83 |
chr3_79887847_79889192 | 5.61 |
Gm36569 |
predicted gene, 36569 |
1713 |
0.31 |
chr1_51291546_51292409 | 5.56 |
Cavin2 |
caveolae associated 2 |
2851 |
0.27 |
chr8_47351619_47352381 | 5.30 |
Stox2 |
storkhead box 2 |
348 |
0.91 |
chr14_69767927_69768467 | 5.26 |
Tnfrsf10b |
tumor necrosis factor receptor superfamily, member 10b |
712 |
0.58 |
chr8_57324709_57326732 | 5.22 |
Hand2os1 |
Hand2, opposite strand 1 |
1487 |
0.3 |
chr11_43834010_43835381 | 5.19 |
Adra1b |
adrenergic receptor, alpha 1b |
1637 |
0.47 |
chr6_119195676_119196202 | 5.15 |
Cacna1c |
calcium channel, voltage-dependent, L type, alpha 1C subunit |
292 |
0.91 |
chr18_61651079_61652393 | 5.01 |
Mir143 |
microRNA 143 |
2478 |
0.16 |
chr6_136875262_136875841 | 5.00 |
Mgp |
matrix Gla protein |
230 |
0.87 |
chr3_102086617_102087454 | 4.95 |
Casq2 |
calsequestrin 2 |
396 |
0.81 |
chr1_17601856_17602960 | 4.95 |
Pi15 |
peptidase inhibitor 15 |
507 |
0.82 |
chr16_38364563_38365451 | 4.72 |
Popdc2 |
popeye domain containing 2 |
2762 |
0.17 |
chr15_79112032_79112287 | 4.61 |
Micall1 |
microtubule associated monooxygenase, calponin and LIM domain containing -like 1 |
2829 |
0.13 |
chr17_71025887_71026476 | 4.50 |
Myom1 |
myomesin 1 |
6590 |
0.13 |
chr5_151127038_151127593 | 4.50 |
Stard13 |
StAR-related lipid transfer (START) domain containing 13 |
228 |
0.95 |
chr6_85371815_85372854 | 4.39 |
Rab11fip5 |
RAB11 family interacting protein 5 (class I) |
2230 |
0.24 |
chr6_24599678_24600100 | 4.39 |
Lmod2 |
leiomodin 2 (cardiac) |
2127 |
0.25 |
chr1_75360071_75361415 | 4.29 |
Des |
desmin |
414 |
0.72 |
chr6_71261026_71261496 | 4.29 |
Smyd1 |
SET and MYND domain containing 1 |
971 |
0.38 |
chr19_36734245_36734714 | 4.18 |
Ppp1r3c |
protein phosphatase 1, regulatory subunit 3C |
2174 |
0.34 |
chr2_76981039_76981308 | 4.14 |
Ttn |
titin |
991 |
0.63 |
chr6_14754259_14754642 | 4.14 |
Ppp1r3a |
protein phosphatase 1, regulatory subunit 3A |
824 |
0.77 |
chr14_20663037_20663711 | 4.06 |
Synpo2l |
synaptopodin 2-like |
1200 |
0.26 |
chr6_24598951_24599156 | 4.04 |
Lmod2 |
leiomodin 2 (cardiac) |
1291 |
0.38 |
chr6_97929540_97930859 | 4.01 |
Mitf |
melanogenesis associated transcription factor |
400 |
0.89 |
chr3_20153107_20153379 | 3.99 |
Gyg |
glycogenin |
1826 |
0.36 |
chr18_11056687_11056838 | 3.95 |
Gata6 |
GATA binding protein 6 |
1724 |
0.4 |
chr9_44069968_44070511 | 3.94 |
Usp2 |
ubiquitin specific peptidase 2 |
796 |
0.33 |
chr2_32650084_32650827 | 3.93 |
Mir1954 |
microRNA 1954 |
1874 |
0.14 |
chr1_51288641_51290950 | 3.92 |
Cavin2 |
caveolae associated 2 |
669 |
0.72 |
chr1_188006897_188007904 | 3.88 |
9330162B11Rik |
RIKEN cDNA 9330162B11 gene |
1590 |
0.45 |
chr8_35377821_35378531 | 3.87 |
Ppp1r3b |
protein phosphatase 1, regulatory subunit 3B |
1516 |
0.31 |
chr4_57845019_57846302 | 3.87 |
Pakap |
paralemmin A kinase anchor protein |
412 |
0.86 |
chr2_17458500_17459039 | 3.87 |
Nebl |
nebulette |
1852 |
0.47 |
chr8_104101710_104103631 | 3.85 |
Cdh5 |
cadherin 5 |
1045 |
0.43 |
chr5_119803355_119804193 | 3.82 |
1700021F13Rik |
RIKEN cDNA 1700021F13 gene |
3893 |
0.21 |
chr14_34587287_34588669 | 3.71 |
Ldb3 |
LIM domain binding 3 |
503 |
0.69 |
chr10_109999870_110000265 | 3.70 |
Nav3 |
neuron navigator 3 |
152 |
0.97 |
chr1_51294105_51294669 | 3.63 |
Cavin2 |
caveolae associated 2 |
5261 |
0.21 |
chr10_102512198_102513266 | 3.62 |
Rassf9 |
Ras association (RalGDS/AF-6) domain family (N-terminal) member 9 |
476 |
0.81 |
chr3_20153383_20154068 | 3.62 |
Gyg |
glycogenin |
1344 |
0.46 |
chr12_113141740_113143605 | 3.62 |
Crip2 |
cysteine rich protein 2 |
136 |
0.92 |
chr13_73260273_73261531 | 3.61 |
Irx4 |
Iroquois homeobox 4 |
405 |
0.82 |
chr13_46421773_46422087 | 3.60 |
Rbm24 |
RNA binding motif protein 24 |
108 |
0.98 |
chr19_56388806_56389568 | 3.60 |
Nrap |
nebulin-related anchoring protein |
690 |
0.66 |
chr10_58396489_58397099 | 3.60 |
Lims1 |
LIM and senescent cell antigen-like domains 1 |
2406 |
0.3 |
chr18_65143491_65144494 | 3.59 |
Nedd4l |
neural precursor cell expressed, developmentally down-regulated gene 4-like |
434 |
0.87 |
chr3_135731541_135732007 | 3.59 |
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105 |
40227 |
0.14 |
chr12_103354203_103354890 | 3.58 |
Asb2 |
ankyrin repeat and SOCS box-containing 2 |
1455 |
0.26 |
chr2_69672410_69673170 | 3.55 |
Klhl41 |
kelch-like 41 |
2670 |
0.21 |
chr13_10045820_10046061 | 3.54 |
Gm47411 |
predicted gene, 47411 |
5908 |
0.24 |
chr14_101841178_101841822 | 3.53 |
Lmo7 |
LIM domain only 7 |
681 |
0.79 |
chr7_46097834_46098538 | 3.49 |
Kcnj11 |
potassium inwardly rectifying channel, subfamily J, member 11 |
240 |
0.86 |
chr5_119836883_119837654 | 3.48 |
Tbx5 |
T-box 5 |
1113 |
0.47 |
chr16_76406995_76407601 | 3.43 |
Gm9843 |
predicted gene 9843 |
3646 |
0.24 |
chr3_123233703_123235038 | 3.40 |
Synpo2 |
synaptopodin 2 |
1726 |
0.3 |
chr6_48571388_48572885 | 3.40 |
Rarres2 |
retinoic acid receptor responder (tazarotene induced) 2 |
510 |
0.53 |
chr3_126363591_126364889 | 3.39 |
Arsj |
arylsulfatase J |
556 |
0.8 |
chr17_48431455_48432112 | 3.38 |
Apobec2 |
apolipoprotein B mRNA editing enzyme, catalytic polypeptide 2 |
835 |
0.47 |
chr16_34262099_34262520 | 3.35 |
Kalrn |
kalirin, RhoGEF kinase |
530 |
0.88 |
chr10_107493143_107493696 | 3.34 |
Myf6 |
myogenic factor 6 |
1318 |
0.43 |
chrX_53053916_53055220 | 3.32 |
Mir322 |
microRNA 322 |
219 |
0.66 |
chr2_76805529_76805788 | 3.31 |
Ttn |
titin |
20884 |
0.22 |
chr3_149497202_149497672 | 3.30 |
Gm30382 |
predicted gene, 30382 |
52136 |
0.17 |
chr7_112228733_112229227 | 3.28 |
Mical2 |
microtubule associated monooxygenase, calponin and LIM domain containing 2 |
3090 |
0.35 |
chr2_180387025_180387876 | 3.27 |
B230312C02Rik |
RIKEN cDNA B230312C02 gene |
1565 |
0.24 |
chr8_57326741_57329467 | 3.26 |
Hand2os1 |
Hand2, opposite strand 1 |
3871 |
0.15 |
chr9_79976568_79977294 | 3.25 |
Filip1 |
filamin A interacting protein 1 |
728 |
0.66 |
chr9_77352280_77353245 | 3.24 |
Mlip |
muscular LMNA-interacting protein |
207 |
0.93 |
chr18_11049995_11051717 | 3.22 |
Gata6os |
GATA binding protein 6, opposite strand |
631 |
0.64 |
chr4_86875543_86876182 | 3.22 |
Acer2 |
alkaline ceramidase 2 |
1448 |
0.44 |
chr5_135887594_135889390 | 3.22 |
Hspb1 |
heat shock protein 1 |
474 |
0.68 |
chr15_25942218_25942426 | 3.21 |
Retreg1 |
reticulophagy regulator 1 |
357 |
0.88 |
chr1_118483098_118483274 | 3.20 |
Clasp1 |
CLIP associating protein 1 |
1147 |
0.4 |
chr2_152931122_152933148 | 3.20 |
Foxs1 |
forkhead box S1 |
1073 |
0.38 |
chr8_18740237_18741640 | 3.20 |
Angpt2 |
angiopoietin 2 |
624 |
0.75 |
chr6_91214341_91214693 | 3.19 |
Fbln2 |
fibulin 2 |
1686 |
0.29 |
chr4_133553412_133554126 | 3.18 |
Nr0b2 |
nuclear receptor subfamily 0, group B, member 2 |
393 |
0.72 |
chr6_115990945_115992684 | 3.17 |
Plxnd1 |
plexin D1 |
3191 |
0.2 |
chr10_12911640_12912555 | 3.16 |
B230208H11Rik |
RIKEN cDNA B230208H11 gene |
10993 |
0.19 |
chr9_56866808_56868850 | 3.16 |
Cspg4 |
chondroitin sulfate proteoglycan 4 |
2796 |
0.18 |
chr9_45934059_45934470 | 3.15 |
Tagln |
transgelin |
1310 |
0.24 |
chr5_43516541_43517216 | 3.14 |
C1qtnf7 |
C1q and tumor necrosis factor related protein 7 |
1116 |
0.45 |
chr17_75177945_75179637 | 3.13 |
Ltbp1 |
latent transforming growth factor beta binding protein 1 |
19 |
0.98 |
chr5_12293696_12294060 | 3.12 |
Gm8953 |
predicted gene 8953 |
61909 |
0.12 |
chr14_101867465_101867853 | 3.12 |
Lmo7 |
LIM domain only 7 |
1811 |
0.47 |
chr11_86584969_86585120 | 3.10 |
Mir21a |
microRNA 21a |
886 |
0.47 |
chr11_72408624_72409355 | 3.10 |
Smtnl2 |
smoothelin-like 2 |
2722 |
0.18 |
chr11_110167321_110168450 | 3.09 |
Abca9 |
ATP-binding cassette, sub-family A (ABC1), member 9 |
170 |
0.97 |
chr2_76980010_76980504 | 3.08 |
Ttn |
titin |
75 |
0.98 |
chr14_54964935_54965983 | 3.07 |
Myh6 |
myosin, heavy polypeptide 6, cardiac muscle, alpha |
1115 |
0.21 |
chr2_17459795_17460084 | 3.06 |
Nebl |
nebulette |
682 |
0.8 |
chr10_18845717_18847414 | 3.05 |
Perp |
PERP, TP53 apoptosis effector |
1545 |
0.37 |
chr5_76859510_76859661 | 3.04 |
C530008M17Rik |
RIKEN cDNA C530008M17 gene |
743 |
0.64 |
chr10_120897341_120897906 | 3.04 |
Msrb3 |
methionine sulfoxide reductase B3 |
1478 |
0.27 |
chr10_71157720_71157992 | 3.00 |
Bicc1 |
BicC family RNA binding protein 1 |
1834 |
0.23 |
chr10_127749619_127751660 | 2.99 |
Gpr182 |
G protein-coupled receptor 182 |
1093 |
0.28 |
chr3_51042270_51042900 | 2.99 |
Gm29230 |
predicted gene 29230 |
32271 |
0.16 |
chr3_138067510_138069146 | 2.99 |
Gm5105 |
predicted gene 5105 |
940 |
0.46 |
chr1_162217585_162219370 | 2.98 |
Dnm3os |
dynamin 3, opposite strand |
601 |
0.46 |
chr14_30490880_30491293 | 2.98 |
Cacna1d |
calcium channel, voltage-dependent, L type, alpha 1D subunit |
367 |
0.84 |
chr18_35720849_35722653 | 2.98 |
Ecscr |
endothelial cell surface expressed chemotaxis and apoptosis regulator |
260 |
0.83 |
chr11_90030594_90032253 | 2.97 |
Tmem100 |
transmembrane protein 100 |
1075 |
0.58 |
chr5_116420481_116421179 | 2.96 |
Hspb8 |
heat shock protein 8 |
2034 |
0.22 |
chr19_36733331_36733963 | 2.96 |
Ppp1r3c |
protein phosphatase 1, regulatory subunit 3C |
3006 |
0.28 |
chr6_17310529_17311110 | 2.94 |
Cav1 |
caveolin 1, caveolae protein |
3096 |
0.25 |
chr6_34599135_34600037 | 2.94 |
Cald1 |
caldesmon 1 |
966 |
0.58 |
chrX_138915309_138915460 | 2.94 |
Nrk |
Nik related kinase |
953 |
0.7 |
chrX_59584716_59585665 | 2.94 |
Fgf13 |
fibroblast growth factor 13 |
17119 |
0.28 |
chr5_122093323_122094551 | 2.94 |
Myl2 |
myosin, light polypeptide 2, regulatory, cardiac, slow |
7014 |
0.14 |
chr6_49989852_49990109 | 2.93 |
Gm3455 |
predicted gene 3455 |
61206 |
0.13 |
chr9_32702476_32702775 | 2.92 |
Ets1 |
E26 avian leukemia oncogene 1, 5' domain |
6241 |
0.19 |
chr11_21368409_21368742 | 2.90 |
Gm12043 |
predicted gene 12043 |
1825 |
0.24 |
chr7_118487954_118489114 | 2.90 |
Itpripl2 |
inositol 1,4,5-triphosphate receptor interacting protein-like 2 |
3441 |
0.19 |
chr13_63278777_63280117 | 2.89 |
Gm47602 |
predicted gene, 47602 |
223 |
0.69 |
chr3_146220721_146222114 | 2.87 |
Lpar3 |
lysophosphatidic acid receptor 3 |
454 |
0.82 |
chr14_63945494_63946032 | 2.87 |
Sox7 |
SRY (sex determining region Y)-box 7 |
2090 |
0.29 |
chr6_4005760_4006960 | 2.86 |
Gng11 |
guanine nucleotide binding protein (G protein), gamma 11 |
2456 |
0.24 |
chr9_64015048_64015338 | 2.86 |
Smad6 |
SMAD family member 6 |
1794 |
0.29 |
chr8_108027187_108028441 | 2.85 |
Zfhx3 |
zinc finger homeobox 3 |
33255 |
0.23 |
chr19_47136957_47138509 | 2.84 |
Calhm2 |
calcium homeostasis modulator family member 2 |
561 |
0.6 |
chr19_53793336_53793637 | 2.83 |
Rbm20 |
RNA binding motif protein 20 |
178 |
0.94 |
chr4_88720102_88720858 | 2.83 |
Gm26566 |
predicted gene, 26566 |
1325 |
0.14 |
chr1_150991583_150991734 | 2.83 |
Hmcn1 |
hemicentin 1 |
1393 |
0.42 |
chr15_85653123_85654040 | 2.83 |
Lncppara |
long noncoding RNA near Ppara |
35 |
0.97 |
chr1_186409123_186409970 | 2.81 |
Gm37491 |
predicted gene, 37491 |
62231 |
0.13 |
chr15_41751298_41752572 | 2.81 |
Oxr1 |
oxidation resistance 1 |
234 |
0.95 |
chr17_43389439_43390317 | 2.80 |
Adgrf5 |
adhesion G protein-coupled receptor F5 |
390 |
0.89 |
chr11_40775441_40775672 | 2.79 |
Ccng1 |
cyclin G1 |
20245 |
0.18 |
chr11_96849614_96850740 | 2.79 |
Mir152 |
microRNA 152 |
216 |
0.56 |
chr2_164403990_164405371 | 2.79 |
Matn4 |
matrilin 4 |
66 |
0.93 |
chr9_75777739_75778295 | 2.77 |
Bmp5 |
bone morphogenetic protein 5 |
2653 |
0.3 |
chr14_20667325_20668286 | 2.77 |
Synpo2l |
synaptopodin 2-like |
501 |
0.59 |
chr4_31404597_31405733 | 2.76 |
Gm11922 |
predicted gene 11922 |
24693 |
0.28 |
chr1_118483733_118484167 | 2.75 |
Clasp1 |
CLIP associating protein 1 |
1911 |
0.25 |
chr10_8944239_8945864 | 2.75 |
Gm48728 |
predicted gene, 48728 |
6898 |
0.2 |
chr3_96560509_96561681 | 2.74 |
Txnip |
thioredoxin interacting protein |
1041 |
0.27 |
chr12_52856330_52856518 | 2.73 |
Akap6 |
A kinase (PRKA) anchor protein 6 |
60588 |
0.14 |
chr17_48430197_48430460 | 2.72 |
Apobec2 |
apolipoprotein B mRNA editing enzyme, catalytic polypeptide 2 |
2290 |
0.18 |
chr11_30264841_30265054 | 2.71 |
Sptbn1 |
spectrin beta, non-erythrocytic 1 |
2267 |
0.31 |
chr3_79783789_79784614 | 2.70 |
Rxfp1 |
relaxin/insulin-like family peptide receptor 1 |
46321 |
0.11 |
chr13_12320444_12320698 | 2.68 |
Actn2 |
actinin alpha 2 |
20153 |
0.16 |
chr8_33927475_33928014 | 2.68 |
Rbpms |
RNA binding protein gene with multiple splicing |
1532 |
0.38 |
chr10_116303263_116304250 | 2.68 |
Ptprb |
protein tyrosine phosphatase, receptor type, B |
2384 |
0.28 |
chr16_14289992_14290622 | 2.68 |
Myh11 |
myosin, heavy polypeptide 11, smooth muscle |
1056 |
0.47 |
chr15_12010211_12011091 | 2.67 |
Sub1 |
SUB1 homolog, transcriptional regulator |
13668 |
0.16 |
chr14_101884566_101885570 | 2.66 |
Lmo7 |
LIM domain only 7 |
949 |
0.69 |
chr1_51597257_51597674 | 2.66 |
Gm17767 |
predicted gene, 17767 |
747 |
0.73 |
chr4_141421681_141422558 | 2.64 |
Hspb7 |
heat shock protein family, member 7 (cardiovascular) |
1340 |
0.25 |
chr7_112956295_112957421 | 2.61 |
Rassf10 |
Ras association (RalGDS/AF-6) domain family (N-terminal) member 10 |
2896 |
0.26 |
chr7_19411651_19412289 | 2.61 |
Ckm |
creatine kinase, muscle |
907 |
0.3 |
chr5_148265188_148266164 | 2.60 |
Mtus2 |
microtubule associated tumor suppressor candidate 2 |
331 |
0.91 |
chr14_34378252_34379423 | 2.59 |
Mmrn2 |
multimerin 2 |
3116 |
0.15 |
chr2_112296591_112296745 | 2.58 |
Slc12a6 |
solute carrier family 12, member 6 |
12091 |
0.13 |
chr8_104629629_104629943 | 2.58 |
Gm33023 |
predicted gene, 33023 |
1046 |
0.27 |
chr14_63235525_63236294 | 2.58 |
Gata4 |
GATA binding protein 4 |
9339 |
0.17 |
chr2_35256357_35257763 | 2.58 |
Gsn |
gelsolin |
611 |
0.67 |
chr12_108370973_108372659 | 2.57 |
Eml1 |
echinoderm microtubule associated protein like 1 |
859 |
0.58 |
chr10_33083089_33083332 | 2.57 |
Trdn |
triadin |
273 |
0.94 |
chr17_26851775_26852396 | 2.57 |
Nkx2-5 |
NK2 homeobox 5 |
7076 |
0.11 |
chr4_53886310_53887240 | 2.57 |
Gm12468 |
predicted gene 12468 |
8850 |
0.17 |
chr18_69523224_69524043 | 2.56 |
Tcf4 |
transcription factor 4 |
1183 |
0.58 |
chr16_43475505_43475718 | 2.55 |
Zbtb20 |
zinc finger and BTB domain containing 20 |
28003 |
0.19 |
chr3_60529662_60530216 | 2.54 |
Mbnl1 |
muscleblind like splicing factor 1 |
308 |
0.91 |
chr1_180703341_180703767 | 2.53 |
Mixl1 |
Mix1 homeobox-like 1 (Xenopus laevis) |
6520 |
0.13 |
chr6_145182304_145182499 | 2.52 |
Gm15543 |
predicted gene 15543 |
126 |
0.94 |
chr1_156838616_156839715 | 2.51 |
Angptl1 |
angiopoietin-like 1 |
223 |
0.86 |
chr11_55417729_55419811 | 2.51 |
Sparc |
secreted acidic cysteine rich glycoprotein |
1128 |
0.44 |
chr3_52984066_52984519 | 2.51 |
Cog6 |
component of oligomeric golgi complex 6 |
10393 |
0.15 |
chr14_101839786_101841002 | 2.51 |
Lmo7 |
LIM domain only 7 |
97 |
0.98 |
chr13_12101498_12102642 | 2.50 |
Ryr2 |
ryanodine receptor 2, cardiac |
4389 |
0.22 |
chr8_35837535_35838051 | 2.50 |
Cldn23 |
claudin 23 |
11234 |
0.17 |
chr10_40629573_40630564 | 2.50 |
Ddo |
D-aspartate oxidase |
9 |
0.98 |
chr10_94545272_94546349 | 2.49 |
Tmcc3 |
transmembrane and coiled coil domains 3 |
379 |
0.87 |
chr14_46965863_46966367 | 2.49 |
Gm15562 |
predicted gene 15562 |
4675 |
0.16 |
chr5_92387344_92388012 | 2.49 |
Art3 |
ADP-ribosyltransferase 3 |
85 |
0.95 |
chr6_55203433_55204260 | 2.49 |
Mindy4 |
MINDY lysine 48 deubiquitinase 4 |
463 |
0.81 |
chr16_92398225_92398526 | 2.48 |
Rcan1 |
regulator of calcineurin 1 |
1603 |
0.3 |
chr8_12926230_12928559 | 2.48 |
Mcf2l |
mcf.2 transforming sequence-like |
762 |
0.52 |
chr3_79884429_79885439 | 2.48 |
Gask1b |
golgi associated kinase 1B |
3 |
0.97 |
chr12_34498957_34499441 | 2.47 |
Hdac9 |
histone deacetylase 9 |
29105 |
0.25 |
chr3_117988466_117988714 | 2.47 |
4921521D15Rik |
RIKEN cDNA 4921521D15 gene |
19460 |
0.25 |
chr13_46523946_46524266 | 2.47 |
Gm24915 |
predicted gene, 24915 |
5422 |
0.2 |
chr18_45945975_45946689 | 2.47 |
Gm26262 |
predicted gene, 26262 |
5325 |
0.28 |
chr2_110360491_110361293 | 2.47 |
Fibin |
fin bud initiation factor homolog (zebrafish) |
2291 |
0.34 |
chr1_135836765_135837624 | 2.46 |
Tnnt2 |
troponin T2, cardiac |
781 |
0.54 |
chr5_118876831_118877755 | 2.46 |
Gm43782 |
predicted gene 43782 |
172 |
0.96 |
chr18_61663030_61663726 | 2.46 |
Carmn |
cardiac mesoderm enhancer-associated non-coding RNA |
2112 |
0.18 |
chr1_189775009_189775805 | 2.46 |
Ptpn14 |
protein tyrosine phosphatase, non-receptor type 14 |
11229 |
0.19 |
chr9_24777033_24778375 | 2.46 |
Gm29824 |
predicted gene, 29824 |
1237 |
0.44 |
chr7_31054545_31055836 | 2.45 |
Fxyd1 |
FXYD domain-containing ion transport regulator 1 |
219 |
0.84 |
chr5_112956864_112957245 | 2.45 |
Grk3 |
G protein-coupled receptor kinase 3 |
31256 |
0.15 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.5 | 13.8 | GO:0035995 | detection of muscle stretch(GO:0035995) |
2.8 | 8.3 | GO:0051891 | positive regulation of cardioblast differentiation(GO:0051891) |
2.7 | 5.3 | GO:0086045 | membrane depolarization during AV node cell action potential(GO:0086045) |
2.3 | 9.1 | GO:0060486 | Clara cell differentiation(GO:0060486) |
2.3 | 6.8 | GO:0003289 | atrial septum primum morphogenesis(GO:0003289) |
1.9 | 9.6 | GO:0071415 | cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
1.9 | 7.6 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
1.8 | 5.4 | GO:0003278 | apoptotic process involved in heart morphogenesis(GO:0003278) |
1.7 | 3.5 | GO:0003166 | bundle of His development(GO:0003166) |
1.7 | 8.6 | GO:0055009 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
1.7 | 5.1 | GO:0007525 | somatic muscle development(GO:0007525) |
1.7 | 6.8 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
1.7 | 5.0 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
1.6 | 4.7 | GO:2000598 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
1.5 | 4.6 | GO:0061366 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
1.5 | 4.5 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
1.5 | 3.0 | GO:0036023 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
1.5 | 5.9 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
1.5 | 1.5 | GO:0051890 | regulation of cardioblast differentiation(GO:0051890) |
1.3 | 4.0 | GO:1903984 | positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
1.3 | 11.4 | GO:0042693 | muscle cell fate commitment(GO:0042693) |
1.2 | 4.9 | GO:0001996 | positive regulation of heart rate by epinephrine-norepinephrine(GO:0001996) |
1.2 | 1.2 | GO:0003164 | His-Purkinje system development(GO:0003164) |
1.1 | 3.4 | GO:0060686 | negative regulation of prostatic bud formation(GO:0060686) |
1.1 | 3.3 | GO:0060510 | Type II pneumocyte differentiation(GO:0060510) |
1.1 | 4.4 | GO:0003175 | tricuspid valve development(GO:0003175) |
1.1 | 2.2 | GO:2000729 | mesenchymal cell proliferation involved in ureter development(GO:0072198) regulation of mesenchymal cell proliferation involved in ureter development(GO:0072199) positive regulation of mesenchymal cell proliferation involved in ureter development(GO:2000729) |
1.1 | 3.3 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
1.1 | 3.2 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
1.1 | 7.5 | GO:0010715 | regulation of extracellular matrix disassembly(GO:0010715) |
1.1 | 7.4 | GO:0098911 | regulation of ventricular cardiac muscle cell action potential(GO:0098911) |
1.1 | 3.2 | GO:1902608 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
1.1 | 3.2 | GO:0045297 | mating plug formation(GO:0042628) post-mating behavior(GO:0045297) |
1.0 | 3.1 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
1.0 | 2.1 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
1.0 | 12.4 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
1.0 | 4.1 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
1.0 | 4.1 | GO:0030035 | microspike assembly(GO:0030035) |
1.0 | 3.0 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
1.0 | 10.0 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
1.0 | 5.9 | GO:1990000 | amyloid fibril formation(GO:1990000) |
1.0 | 1.0 | GO:0061325 | cell proliferation involved in outflow tract morphogenesis(GO:0061325) |
1.0 | 2.9 | GO:0060523 | prostate epithelial cord elongation(GO:0060523) |
1.0 | 1.9 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
1.0 | 1.0 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
1.0 | 5.7 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
0.9 | 3.6 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
0.9 | 2.7 | GO:0006533 | aspartate catabolic process(GO:0006533) |
0.9 | 4.5 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.9 | 1.8 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.9 | 4.4 | GO:0086013 | membrane repolarization during cardiac muscle cell action potential(GO:0086013) |
0.9 | 4.4 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.9 | 4.4 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.9 | 1.7 | GO:1904261 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
0.9 | 0.9 | GO:0090259 | regulation of retinal ganglion cell axon guidance(GO:0090259) |
0.9 | 1.7 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
0.9 | 5.2 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.9 | 1.7 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
0.9 | 2.6 | GO:0072104 | glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) metanephric glomerulus morphogenesis(GO:0072275) metanephric glomerulus vasculature morphogenesis(GO:0072276) metanephric glomerular capillary formation(GO:0072277) |
0.8 | 1.7 | GO:0033505 | floor plate morphogenesis(GO:0033505) |
0.8 | 3.4 | GO:0032348 | negative regulation of aldosterone metabolic process(GO:0032345) negative regulation of aldosterone biosynthetic process(GO:0032348) negative regulation of cortisol biosynthetic process(GO:2000065) |
0.8 | 2.5 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.8 | 2.5 | GO:2000857 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.8 | 6.6 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.8 | 3.3 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
0.8 | 3.3 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.8 | 1.6 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
0.8 | 3.1 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
0.8 | 3.0 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.8 | 3.0 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.7 | 3.0 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.7 | 2.2 | GO:0010694 | positive regulation of alkaline phosphatase activity(GO:0010694) |
0.7 | 2.2 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.7 | 1.5 | GO:0003104 | positive regulation of glomerular filtration(GO:0003104) |
0.7 | 0.7 | GO:0060685 | single-organism reproductive behavior(GO:0044704) regulation of prostatic bud formation(GO:0060685) |
0.7 | 1.4 | GO:2000823 | regulation of androgen receptor activity(GO:2000823) |
0.7 | 2.2 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
0.7 | 0.7 | GO:0072106 | regulation of ureteric bud formation(GO:0072106) positive regulation of ureteric bud formation(GO:0072107) |
0.7 | 1.4 | GO:0048818 | positive regulation of hair follicle maturation(GO:0048818) |
0.7 | 3.5 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
0.7 | 7.0 | GO:0032060 | bleb assembly(GO:0032060) |
0.7 | 2.1 | GO:0034140 | negative regulation of toll-like receptor 3 signaling pathway(GO:0034140) |
0.7 | 2.1 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.7 | 2.1 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.7 | 1.4 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.7 | 2.0 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
0.7 | 1.4 | GO:0032512 | regulation of protein phosphatase type 2B activity(GO:0032512) |
0.7 | 1.3 | GO:2000591 | positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:0035793) regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:1900238) positive regulation of metanephric mesenchymal cell migration(GO:2000591) |
0.7 | 4.0 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.7 | 3.3 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.7 | 0.7 | GO:0061047 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) positive regulation of branching involved in lung morphogenesis(GO:0061047) |
0.7 | 2.6 | GO:0007494 | midgut development(GO:0007494) |
0.7 | 3.3 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.7 | 1.3 | GO:0071673 | positive regulation of smooth muscle cell chemotaxis(GO:0071673) |
0.7 | 2.6 | GO:1900147 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
0.7 | 0.7 | GO:0048295 | positive regulation of isotype switching to IgE isotypes(GO:0048295) |
0.6 | 1.9 | GO:0003032 | detection of oxygen(GO:0003032) |
0.6 | 3.2 | GO:0010957 | negative regulation of vitamin D biosynthetic process(GO:0010957) |
0.6 | 1.3 | GO:0060931 | sinoatrial node cell development(GO:0060931) |
0.6 | 3.8 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.6 | 1.3 | GO:0070384 | Harderian gland development(GO:0070384) |
0.6 | 1.3 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
0.6 | 4.4 | GO:1901077 | regulation of relaxation of muscle(GO:1901077) |
0.6 | 1.8 | GO:0060437 | lung growth(GO:0060437) |
0.6 | 2.4 | GO:1903278 | positive regulation of sodium ion export(GO:1903275) positive regulation of sodium ion export from cell(GO:1903278) |
0.6 | 4.3 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.6 | 1.8 | GO:0061074 | regulation of neural retina development(GO:0061074) |
0.6 | 1.8 | GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
0.6 | 0.6 | GO:0032347 | regulation of aldosterone biosynthetic process(GO:0032347) |
0.6 | 0.6 | GO:0060315 | negative regulation of ryanodine-sensitive calcium-release channel activity(GO:0060315) |
0.6 | 2.4 | GO:0090611 | ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
0.6 | 1.2 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
0.6 | 3.6 | GO:0043116 | negative regulation of vascular permeability(GO:0043116) |
0.6 | 4.2 | GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
0.6 | 1.8 | GO:2001280 | positive regulation of prostaglandin biosynthetic process(GO:0031394) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
0.6 | 1.8 | GO:0035284 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.6 | 7.5 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
0.6 | 1.7 | GO:1902744 | negative regulation of lamellipodium organization(GO:1902744) |
0.6 | 2.3 | GO:0032497 | detection of lipopolysaccharide(GO:0032497) |
0.6 | 0.6 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.6 | 1.7 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
0.6 | 1.7 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.6 | 3.4 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.6 | 2.2 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
0.6 | 1.7 | GO:0036493 | positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
0.5 | 1.6 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
0.5 | 1.6 | GO:0003383 | apical constriction(GO:0003383) |
0.5 | 8.6 | GO:0014850 | response to muscle activity(GO:0014850) |
0.5 | 1.1 | GO:0032079 | positive regulation of endodeoxyribonuclease activity(GO:0032079) |
0.5 | 0.5 | GO:0014829 | vascular smooth muscle contraction(GO:0014829) |
0.5 | 1.6 | GO:0051466 | positive regulation of corticotropin-releasing hormone secretion(GO:0051466) |
0.5 | 1.6 | GO:0090283 | regulation of protein glycosylation in Golgi(GO:0090283) |
0.5 | 1.1 | GO:0014738 | regulation of muscle hyperplasia(GO:0014738) muscle hyperplasia(GO:0014900) |
0.5 | 1.1 | GO:2000138 | positive regulation of cell proliferation involved in heart morphogenesis(GO:2000138) |
0.5 | 3.7 | GO:0014820 | tonic smooth muscle contraction(GO:0014820) |
0.5 | 3.7 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.5 | 4.1 | GO:0031272 | regulation of pseudopodium assembly(GO:0031272) |
0.5 | 0.5 | GO:0010612 | regulation of cardiac muscle adaptation(GO:0010612) regulation of cardiac muscle hypertrophy in response to stress(GO:1903242) |
0.5 | 1.5 | GO:0032353 | negative regulation of hormone biosynthetic process(GO:0032353) |
0.5 | 0.5 | GO:0051794 | regulation of catagen(GO:0051794) |
0.5 | 3.0 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.5 | 1.5 | GO:2000645 | negative regulation of receptor catabolic process(GO:2000645) |
0.5 | 1.5 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
0.5 | 2.0 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.5 | 1.5 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.5 | 1.0 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.5 | 3.9 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.5 | 1.0 | GO:0097168 | mesenchymal stem cell proliferation(GO:0097168) |
0.5 | 1.9 | GO:0072592 | oxygen metabolic process(GO:0072592) |
0.5 | 1.0 | GO:0035984 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
0.5 | 0.5 | GO:0003308 | negative regulation of Wnt signaling pathway involved in heart development(GO:0003308) |
0.5 | 1.9 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
0.5 | 1.0 | GO:0001757 | somite specification(GO:0001757) |
0.5 | 0.9 | GO:0006068 | ethanol catabolic process(GO:0006068) |
0.5 | 2.8 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
0.5 | 4.3 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.5 | 1.4 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
0.5 | 1.8 | GO:1901552 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.5 | 0.9 | GO:2000391 | regulation of neutrophil extravasation(GO:2000389) positive regulation of neutrophil extravasation(GO:2000391) |
0.5 | 0.5 | GO:0038095 | Fc-epsilon receptor signaling pathway(GO:0038095) |
0.5 | 8.7 | GO:0045214 | sarcomere organization(GO:0045214) |
0.5 | 0.9 | GO:0071502 | cellular response to temperature stimulus(GO:0071502) |
0.5 | 2.3 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.5 | 1.4 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.5 | 1.4 | GO:0030421 | defecation(GO:0030421) |
0.4 | 2.7 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.4 | 1.3 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.4 | 2.7 | GO:0030239 | myofibril assembly(GO:0030239) |
0.4 | 1.3 | GO:0051284 | negative regulation of release of sequestered calcium ion into cytosol(GO:0051280) positive regulation of sequestering of calcium ion(GO:0051284) |
0.4 | 1.8 | GO:0060662 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
0.4 | 9.3 | GO:0010107 | potassium ion import(GO:0010107) |
0.4 | 0.4 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
0.4 | 0.4 | GO:2000195 | negative regulation of female gonad development(GO:2000195) |
0.4 | 1.3 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.4 | 0.9 | GO:2001028 | positive regulation of endothelial cell chemotaxis(GO:2001028) |
0.4 | 0.9 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
0.4 | 0.4 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.4 | 0.9 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
0.4 | 1.7 | GO:0035989 | tendon development(GO:0035989) |
0.4 | 0.4 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
0.4 | 0.4 | GO:0072095 | regulation of branch elongation involved in ureteric bud branching(GO:0072095) |
0.4 | 3.7 | GO:0035810 | positive regulation of urine volume(GO:0035810) |
0.4 | 2.1 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.4 | 1.2 | GO:1902548 | negative regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902548) |
0.4 | 1.2 | GO:0070340 | detection of bacterial lipopeptide(GO:0070340) |
0.4 | 3.6 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) |
0.4 | 1.2 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
0.4 | 1.6 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
0.4 | 2.0 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.4 | 1.6 | GO:1900086 | regulation of peptidyl-tyrosine autophosphorylation(GO:1900084) positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
0.4 | 1.6 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.4 | 0.4 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.4 | 2.7 | GO:0060613 | fat pad development(GO:0060613) |
0.4 | 1.5 | GO:1903012 | positive regulation of bone development(GO:1903012) |
0.4 | 1.9 | GO:0051775 | response to redox state(GO:0051775) |
0.4 | 0.7 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
0.4 | 1.5 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.4 | 1.1 | GO:0008582 | regulation of synaptic growth at neuromuscular junction(GO:0008582) |
0.4 | 1.1 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
0.4 | 5.1 | GO:0014741 | negative regulation of muscle hypertrophy(GO:0014741) |
0.4 | 0.7 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
0.4 | 3.7 | GO:2000400 | positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
0.4 | 0.7 | GO:0001698 | gastrin-induced gastric acid secretion(GO:0001698) |
0.4 | 1.1 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.4 | 1.1 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
0.4 | 1.1 | GO:0001978 | regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback(GO:0001978) |
0.4 | 2.2 | GO:1902913 | positive regulation of neuroepithelial cell differentiation(GO:1902913) |
0.4 | 1.4 | GO:2000525 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
0.4 | 1.4 | GO:0030091 | protein repair(GO:0030091) |
0.4 | 0.7 | GO:2001027 | negative regulation of endothelial cell chemotaxis(GO:2001027) |
0.3 | 0.7 | GO:2000836 | androgen secretion(GO:0035935) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) |
0.3 | 1.0 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.3 | 1.0 | GO:0046544 | development of secondary male sexual characteristics(GO:0046544) |
0.3 | 1.4 | GO:0030049 | muscle filament sliding(GO:0030049) |
0.3 | 0.7 | GO:0071374 | cellular response to parathyroid hormone stimulus(GO:0071374) |
0.3 | 1.0 | GO:0015889 | cobalamin transport(GO:0015889) |
0.3 | 0.3 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
0.3 | 0.3 | GO:0060353 | regulation of cell adhesion molecule production(GO:0060353) |
0.3 | 1.0 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.3 | 2.0 | GO:0006145 | purine nucleobase catabolic process(GO:0006145) |
0.3 | 1.0 | GO:0046103 | inosine biosynthetic process(GO:0046103) |
0.3 | 2.0 | GO:0098908 | regulation of neuronal action potential(GO:0098908) |
0.3 | 0.3 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
0.3 | 0.3 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
0.3 | 1.6 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.3 | 1.3 | GO:0001765 | membrane raft assembly(GO:0001765) |
0.3 | 2.0 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.3 | 1.3 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
0.3 | 1.6 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
0.3 | 0.6 | GO:0060161 | positive regulation of dopamine receptor signaling pathway(GO:0060161) |
0.3 | 1.0 | GO:0007567 | parturition(GO:0007567) |
0.3 | 1.3 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.3 | 0.3 | GO:1903818 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
0.3 | 1.6 | GO:0010917 | negative regulation of mitochondrial membrane potential(GO:0010917) |
0.3 | 0.3 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
0.3 | 0.6 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
0.3 | 0.6 | GO:0036296 | response to increased oxygen levels(GO:0036296) response to hyperoxia(GO:0055093) |
0.3 | 0.6 | GO:0035880 | embryonic nail plate morphogenesis(GO:0035880) |
0.3 | 1.2 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
0.3 | 0.6 | GO:1904338 | regulation of dopaminergic neuron differentiation(GO:1904338) regulation of midbrain dopaminergic neuron differentiation(GO:1904956) |
0.3 | 1.8 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.3 | 0.3 | GO:1902837 | amino acid import into cell(GO:1902837) |
0.3 | 0.9 | GO:0045196 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
0.3 | 1.5 | GO:1903817 | negative regulation of delayed rectifier potassium channel activity(GO:1902260) negative regulation of voltage-gated potassium channel activity(GO:1903817) |
0.3 | 0.6 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.3 | 0.9 | GO:2000977 | regulation of forebrain neuron differentiation(GO:2000977) |
0.3 | 2.1 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.3 | 0.3 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
0.3 | 0.9 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.3 | 0.6 | GO:0007403 | glial cell fate determination(GO:0007403) |
0.3 | 1.7 | GO:0048664 | neuron fate determination(GO:0048664) |
0.3 | 0.6 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.3 | 0.9 | GO:0002606 | positive regulation of dendritic cell antigen processing and presentation(GO:0002606) |
0.3 | 1.7 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
0.3 | 0.3 | GO:0034310 | primary alcohol catabolic process(GO:0034310) |
0.3 | 0.6 | GO:0061152 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.3 | 0.3 | GO:1901201 | regulation of extracellular matrix assembly(GO:1901201) |
0.3 | 0.9 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.3 | 0.6 | GO:0060513 | prostatic bud formation(GO:0060513) |
0.3 | 0.9 | GO:0046271 | phenylpropanoid catabolic process(GO:0046271) |
0.3 | 0.8 | GO:0016095 | polyprenol catabolic process(GO:0016095) |
0.3 | 0.6 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.3 | 0.8 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
0.3 | 0.8 | GO:0015888 | thiamine transport(GO:0015888) |
0.3 | 0.3 | GO:0042713 | sperm ejaculation(GO:0042713) |
0.3 | 0.8 | GO:0002018 | renin-angiotensin regulation of aldosterone production(GO:0002018) |
0.3 | 0.8 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.3 | 0.3 | GO:0086068 | Purkinje myocyte to ventricular cardiac muscle cell signaling(GO:0086029) Purkinje myocyte to ventricular cardiac muscle cell communication(GO:0086068) |
0.3 | 0.3 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.3 | 1.4 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.3 | 0.3 | GO:1905063 | regulation of vascular smooth muscle cell differentiation(GO:1905063) positive regulation of vascular smooth muscle cell differentiation(GO:1905065) |
0.3 | 0.6 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.3 | 0.8 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
0.3 | 1.1 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.3 | 0.3 | GO:0003100 | regulation of systemic arterial blood pressure by endothelin(GO:0003100) |
0.3 | 0.8 | GO:0035633 | maintenance of blood-brain barrier(GO:0035633) |
0.3 | 2.7 | GO:0001696 | gastric acid secretion(GO:0001696) |
0.3 | 0.5 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
0.3 | 0.5 | GO:2000987 | regulation of fear response(GO:1903365) positive regulation of fear response(GO:1903367) regulation of behavioral fear response(GO:2000822) positive regulation of behavioral fear response(GO:2000987) |
0.3 | 1.3 | GO:0070842 | aggresome assembly(GO:0070842) |
0.3 | 0.5 | GO:0048850 | hypophysis morphogenesis(GO:0048850) |
0.3 | 1.9 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.3 | 1.9 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.3 | 0.5 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
0.3 | 0.8 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.3 | 0.8 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.3 | 0.8 | GO:0035425 | autocrine signaling(GO:0035425) |
0.3 | 0.5 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.3 | 0.8 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.3 | 1.8 | GO:0001787 | natural killer cell proliferation(GO:0001787) |
0.3 | 1.0 | GO:0033030 | negative regulation of neutrophil apoptotic process(GO:0033030) |
0.3 | 0.5 | GO:0090335 | regulation of brown fat cell differentiation(GO:0090335) |
0.3 | 0.8 | GO:0060336 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
0.3 | 1.3 | GO:0033227 | dsRNA transport(GO:0033227) |
0.3 | 0.5 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.3 | 1.3 | GO:2000343 | positive regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000343) |
0.3 | 2.0 | GO:0035812 | renal sodium excretion(GO:0035812) regulation of renal sodium excretion(GO:0035813) |
0.3 | 4.3 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.3 | 1.3 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
0.3 | 0.5 | GO:0086069 | bundle of His cell to Purkinje myocyte communication(GO:0086069) |
0.3 | 0.3 | GO:0035754 | B cell chemotaxis(GO:0035754) |
0.3 | 0.8 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.3 | 1.0 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.3 | 2.3 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.2 | 1.5 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.2 | 1.2 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.2 | 0.7 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.2 | 0.5 | GO:0050427 | 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.2 | 1.0 | GO:0002934 | desmosome organization(GO:0002934) |
0.2 | 0.7 | GO:0060005 | vestibular reflex(GO:0060005) |
0.2 | 1.0 | GO:0042737 | drug catabolic process(GO:0042737) |
0.2 | 0.5 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
0.2 | 1.7 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.2 | 1.0 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
0.2 | 0.7 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
0.2 | 0.9 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.2 | 0.9 | GO:0060763 | mammary duct terminal end bud growth(GO:0060763) |
0.2 | 0.5 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.2 | 0.7 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.2 | 0.5 | GO:0072180 | mesonephric duct morphogenesis(GO:0072180) |
0.2 | 1.4 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.2 | 1.2 | GO:0061117 | negative regulation of cardiac muscle tissue growth(GO:0055022) negative regulation of heart growth(GO:0061117) |
0.2 | 0.7 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.2 | 0.5 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
0.2 | 0.9 | GO:0019244 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
0.2 | 0.9 | GO:0045618 | positive regulation of keratinocyte differentiation(GO:0045618) |
0.2 | 0.2 | GO:2001198 | regulation of dendritic cell differentiation(GO:2001198) |
0.2 | 1.6 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.2 | 2.1 | GO:0005980 | glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
0.2 | 1.1 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.2 | 0.7 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
0.2 | 1.1 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.2 | 3.4 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.2 | 1.1 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.2 | 1.3 | GO:0097264 | self proteolysis(GO:0097264) |
0.2 | 0.4 | GO:1900127 | positive regulation of hyaluronan biosynthetic process(GO:1900127) |
0.2 | 0.9 | GO:0003334 | keratinocyte development(GO:0003334) |
0.2 | 0.4 | GO:0071798 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.2 | 0.2 | GO:0042520 | positive regulation of tyrosine phosphorylation of Stat4 protein(GO:0042520) |
0.2 | 1.5 | GO:0060445 | branching involved in salivary gland morphogenesis(GO:0060445) |
0.2 | 0.6 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
0.2 | 0.2 | GO:0070343 | white fat cell proliferation(GO:0070343) regulation of white fat cell proliferation(GO:0070350) |
0.2 | 0.4 | GO:0042045 | epithelial fluid transport(GO:0042045) |
0.2 | 0.8 | GO:0035795 | negative regulation of mitochondrial membrane permeability(GO:0035795) |
0.2 | 0.2 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.2 | 0.2 | GO:0009826 | unidimensional cell growth(GO:0009826) |
0.2 | 0.8 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.2 | 0.6 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.2 | 3.4 | GO:0055013 | cardiac muscle cell development(GO:0055013) |
0.2 | 0.4 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
0.2 | 1.3 | GO:0060056 | mammary gland involution(GO:0060056) |
0.2 | 2.1 | GO:0010718 | positive regulation of epithelial to mesenchymal transition(GO:0010718) |
0.2 | 1.5 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.2 | 0.8 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.2 | 1.9 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.2 | 1.2 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.2 | 2.3 | GO:0035879 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.2 | 0.8 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
0.2 | 0.6 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.2 | 1.0 | GO:0060347 | heart trabecula formation(GO:0060347) |
0.2 | 0.4 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
0.2 | 0.8 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.2 | 0.6 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.2 | 0.6 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.2 | 1.0 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
0.2 | 1.2 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.2 | 1.4 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.2 | 0.4 | GO:0007571 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.2 | 1.4 | GO:0060043 | regulation of cardiac muscle cell proliferation(GO:0060043) |
0.2 | 0.8 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
0.2 | 0.6 | GO:0015705 | iodide transport(GO:0015705) |
0.2 | 0.6 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
0.2 | 0.6 | GO:0000430 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) |
0.2 | 0.6 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.2 | 0.6 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
0.2 | 1.0 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
0.2 | 6.1 | GO:0010830 | regulation of myotube differentiation(GO:0010830) |
0.2 | 0.6 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
0.2 | 1.1 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.2 | 0.9 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.2 | 4.8 | GO:0005978 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.2 | 1.9 | GO:0051043 | regulation of membrane protein ectodomain proteolysis(GO:0051043) |
0.2 | 0.2 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
0.2 | 0.6 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
0.2 | 0.6 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.2 | 1.8 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.2 | 0.4 | GO:0099624 | regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) atrial cardiac muscle cell membrane repolarization(GO:0099624) |
0.2 | 1.8 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.2 | 0.5 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.2 | 1.5 | GO:0071801 | regulation of podosome assembly(GO:0071801) |
0.2 | 0.4 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.2 | 0.7 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.2 | 1.2 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
0.2 | 1.2 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.2 | 0.2 | GO:0002125 | maternal aggressive behavior(GO:0002125) |
0.2 | 0.2 | GO:0061535 | glutamate secretion, neurotransmission(GO:0061535) |
0.2 | 0.4 | GO:0061055 | myotome development(GO:0061055) |
0.2 | 0.4 | GO:0071351 | cellular response to interleukin-18(GO:0071351) |
0.2 | 0.2 | GO:0055006 | cardiac cell development(GO:0055006) |
0.2 | 0.4 | GO:1903140 | regulation of endothelial cell development(GO:1901550) regulation of establishment of endothelial barrier(GO:1903140) |
0.2 | 1.2 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
0.2 | 3.9 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.2 | 1.2 | GO:1904322 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.2 | 0.5 | GO:0055012 | ventricular cardiac muscle cell differentiation(GO:0055012) |
0.2 | 3.3 | GO:0010595 | positive regulation of endothelial cell migration(GO:0010595) |
0.2 | 1.0 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.2 | 0.5 | GO:0071732 | cellular response to nitric oxide(GO:0071732) |
0.2 | 0.2 | GO:0042091 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.2 | 1.2 | GO:0002828 | regulation of type 2 immune response(GO:0002828) |
0.2 | 0.8 | GO:0043206 | extracellular fibril organization(GO:0043206) |
0.2 | 0.2 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
0.2 | 0.3 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
0.2 | 0.7 | GO:0046959 | habituation(GO:0046959) |
0.2 | 0.2 | GO:1900020 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
0.2 | 0.8 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
0.2 | 0.5 | GO:0015755 | fructose transport(GO:0015755) |
0.2 | 1.0 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
0.2 | 0.3 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
0.2 | 1.0 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
0.2 | 0.3 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.2 | 0.8 | GO:0071800 | podosome assembly(GO:0071800) |
0.2 | 0.5 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.2 | 0.5 | GO:0045964 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
0.2 | 0.8 | GO:0043416 | regulation of skeletal muscle tissue regeneration(GO:0043416) |
0.2 | 0.2 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.2 | 0.3 | GO:0010613 | positive regulation of cardiac muscle hypertrophy(GO:0010613) positive regulation of muscle hypertrophy(GO:0014742) |
0.2 | 0.3 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.2 | 1.0 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.2 | 0.6 | GO:0042421 | norepinephrine biosynthetic process(GO:0042421) |
0.2 | 2.5 | GO:0044042 | glycogen metabolic process(GO:0005977) cellular glucan metabolic process(GO:0006073) glucan metabolic process(GO:0044042) |
0.2 | 0.5 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.2 | 0.3 | GO:0031033 | myosin filament organization(GO:0031033) |
0.2 | 1.7 | GO:0060088 | auditory receptor cell stereocilium organization(GO:0060088) |
0.2 | 4.5 | GO:0045445 | myoblast differentiation(GO:0045445) |
0.2 | 0.3 | GO:0072338 | creatinine metabolic process(GO:0046449) cellular lactam metabolic process(GO:0072338) |
0.2 | 0.8 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.2 | 0.2 | GO:2000515 | negative regulation of CD4-positive, alpha-beta T cell activation(GO:2000515) |
0.2 | 1.1 | GO:0002053 | positive regulation of mesenchymal cell proliferation(GO:0002053) |
0.2 | 2.9 | GO:0060389 | pathway-restricted SMAD protein phosphorylation(GO:0060389) |
0.2 | 0.8 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
0.2 | 1.1 | GO:0006108 | malate metabolic process(GO:0006108) |
0.2 | 0.5 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.2 | 0.5 | GO:0060355 | positive regulation of cell adhesion molecule production(GO:0060355) |
0.2 | 0.5 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.1 | 0.1 | GO:1902956 | regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902956) |
0.1 | 0.1 | GO:0032621 | interleukin-18 production(GO:0032621) |
0.1 | 0.1 | GO:0001998 | angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001998) |
0.1 | 0.9 | GO:0043616 | keratinocyte proliferation(GO:0043616) |
0.1 | 0.3 | GO:0090148 | membrane fission(GO:0090148) |
0.1 | 0.4 | GO:0060177 | regulation of angiotensin levels in blood(GO:0002002) regulation of angiotensin metabolic process(GO:0060177) |
0.1 | 0.1 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.1 | 0.7 | GO:0070072 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.1 | 0.3 | GO:1901475 | pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
0.1 | 0.6 | GO:0046909 | intermembrane transport(GO:0046909) |
0.1 | 0.3 | GO:0060618 | nipple development(GO:0060618) |
0.1 | 0.3 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
0.1 | 0.1 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.1 | 1.0 | GO:0042905 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.1 | 0.4 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.1 | 0.4 | GO:1901662 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.1 | 0.4 | GO:0036120 | cellular response to platelet-derived growth factor stimulus(GO:0036120) |
0.1 | 0.1 | GO:2000110 | negative regulation of macrophage apoptotic process(GO:2000110) |
0.1 | 0.4 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.1 | 2.8 | GO:0030890 | positive regulation of B cell proliferation(GO:0030890) |
0.1 | 0.4 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.1 | 0.7 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.1 | 0.6 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.1 | 0.1 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
0.1 | 1.0 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.1 | 0.4 | GO:0099515 | actin filament-based transport(GO:0099515) |
0.1 | 0.4 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.1 | 0.1 | GO:0031585 | regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031585) |
0.1 | 0.4 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.1 | 0.1 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.1 | 0.4 | GO:0046087 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.1 | 1.1 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.1 | 0.1 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
0.1 | 1.5 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
0.1 | 0.5 | GO:0051031 | tRNA transport(GO:0051031) |
0.1 | 0.5 | GO:1904754 | vascular associated smooth muscle cell migration(GO:1904738) regulation of vascular associated smooth muscle cell migration(GO:1904752) positive regulation of vascular associated smooth muscle cell migration(GO:1904754) |
0.1 | 0.3 | GO:0043091 | L-arginine import(GO:0043091) arginine import(GO:0090467) L-arginine transport(GO:1902023) |
0.1 | 0.4 | GO:0072033 | renal vesicle formation(GO:0072033) |
0.1 | 0.5 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
0.1 | 0.3 | GO:0017085 | response to insecticide(GO:0017085) |
0.1 | 0.1 | GO:2000169 | regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
0.1 | 0.1 | GO:0002901 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
0.1 | 0.4 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.1 | 1.5 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.1 | 0.5 | GO:0009624 | response to nematode(GO:0009624) |
0.1 | 0.5 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.1 | 0.4 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
0.1 | 0.5 | GO:0003197 | endocardial cushion development(GO:0003197) |
0.1 | 1.9 | GO:1901185 | negative regulation of ERBB signaling pathway(GO:1901185) |
0.1 | 0.1 | GO:0071888 | macrophage apoptotic process(GO:0071888) regulation of macrophage apoptotic process(GO:2000109) |
0.1 | 0.5 | GO:0030311 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.1 | 0.3 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.1 | 0.5 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.1 | 0.7 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
0.1 | 0.4 | GO:0060317 | cardiac epithelial to mesenchymal transition(GO:0060317) |
0.1 | 0.1 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
0.1 | 1.0 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
0.1 | 0.4 | GO:1904751 | regulation of protein localization to nucleolus(GO:1904749) positive regulation of protein localization to nucleolus(GO:1904751) |
0.1 | 0.4 | GO:0060973 | cell migration involved in heart development(GO:0060973) |
0.1 | 0.9 | GO:0007045 | cell-substrate adherens junction assembly(GO:0007045) focal adhesion assembly(GO:0048041) |
0.1 | 0.2 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
0.1 | 0.4 | GO:0002035 | brain renin-angiotensin system(GO:0002035) |
0.1 | 1.0 | GO:0060180 | female mating behavior(GO:0060180) |
0.1 | 0.1 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.1 | 0.4 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
0.1 | 0.2 | GO:1903371 | regulation of endoplasmic reticulum tubular network organization(GO:1903371) |
0.1 | 0.6 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.1 | 0.4 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.1 | 0.4 | GO:1902894 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
0.1 | 0.4 | GO:0003105 | negative regulation of glomerular filtration(GO:0003105) |
0.1 | 0.1 | GO:0032252 | secretory granule localization(GO:0032252) |
0.1 | 0.1 | GO:0048597 | post-embryonic camera-type eye morphogenesis(GO:0048597) |
0.1 | 0.5 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
0.1 | 0.2 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
0.1 | 0.1 | GO:0048143 | astrocyte activation(GO:0048143) |
0.1 | 0.9 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.1 | 0.2 | GO:0090598 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.1 | 0.5 | GO:0002645 | positive regulation of tolerance induction(GO:0002645) |
0.1 | 0.7 | GO:0033692 | cellular polysaccharide biosynthetic process(GO:0033692) |
0.1 | 1.4 | GO:0042481 | regulation of odontogenesis(GO:0042481) |
0.1 | 0.2 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
0.1 | 0.1 | GO:2001046 | positive regulation of integrin-mediated signaling pathway(GO:2001046) |
0.1 | 0.1 | GO:0002576 | platelet degranulation(GO:0002576) |
0.1 | 0.6 | GO:0019732 | antifungal humoral response(GO:0019732) |
0.1 | 0.3 | GO:0036303 | lymphangiogenesis(GO:0001946) lymph vessel morphogenesis(GO:0036303) |
0.1 | 0.7 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.1 | 0.3 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.1 | 0.6 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.1 | 0.4 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
0.1 | 0.1 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.1 | 1.8 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.1 | 0.4 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
0.1 | 0.3 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
0.1 | 0.8 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.1 | 0.1 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
0.1 | 0.1 | GO:0010980 | regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
0.1 | 3.6 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
0.1 | 0.4 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.1 | 0.9 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.1 | 0.3 | GO:0071236 | cellular response to antibiotic(GO:0071236) |
0.1 | 1.0 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.1 | 0.2 | GO:0033085 | negative regulation of T cell differentiation in thymus(GO:0033085) |
0.1 | 0.4 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.1 | 0.3 | GO:0042097 | interleukin-4 biosynthetic process(GO:0042097) regulation of interleukin-4 biosynthetic process(GO:0045402) positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
0.1 | 0.2 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
0.1 | 0.2 | GO:0072602 | interleukin-4 secretion(GO:0072602) |
0.1 | 0.6 | GO:1902510 | regulation of apoptotic DNA fragmentation(GO:1902510) |
0.1 | 0.1 | GO:0060750 | epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) |
0.1 | 0.6 | GO:0048368 | lateral mesoderm development(GO:0048368) |
0.1 | 0.2 | GO:0032196 | transposition(GO:0032196) |
0.1 | 0.3 | GO:0060037 | pharyngeal system development(GO:0060037) |
0.1 | 0.3 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.1 | 0.5 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
0.1 | 0.4 | GO:0070166 | enamel mineralization(GO:0070166) |
0.1 | 0.3 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.1 | 0.3 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.1 | 0.2 | GO:1904526 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
0.1 | 1.3 | GO:0017144 | drug metabolic process(GO:0017144) |
0.1 | 0.5 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.1 | 1.5 | GO:0045109 | intermediate filament organization(GO:0045109) |
0.1 | 0.2 | GO:0033210 | leptin-mediated signaling pathway(GO:0033210) |
0.1 | 0.2 | GO:0034505 | tooth mineralization(GO:0034505) |
0.1 | 0.1 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
0.1 | 0.1 | GO:0032071 | regulation of endodeoxyribonuclease activity(GO:0032071) |
0.1 | 0.2 | GO:0098801 | regulation of renal system process(GO:0098801) |
0.1 | 1.1 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.1 | 0.2 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.1 | 0.1 | GO:0090218 | positive regulation of lipid kinase activity(GO:0090218) |
0.1 | 0.4 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.1 | 0.3 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.1 | 0.3 | GO:0051639 | actin filament network formation(GO:0051639) |
0.1 | 0.2 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.1 | 0.2 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
0.1 | 0.3 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
0.1 | 0.8 | GO:0045475 | locomotor rhythm(GO:0045475) |
0.1 | 0.1 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.1 | 0.3 | GO:0090230 | regulation of centromere complex assembly(GO:0090230) |
0.1 | 0.5 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.1 | 0.3 | GO:1903232 | melanosome assembly(GO:1903232) |
0.1 | 0.3 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
0.1 | 0.2 | GO:2000143 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) negative regulation of DNA-templated transcription, initiation(GO:2000143) |
0.1 | 0.3 | GO:0072711 | response to hydroxyurea(GO:0072710) cellular response to hydroxyurea(GO:0072711) |
0.1 | 0.3 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.1 | 0.3 | GO:0045356 | positive regulation of interferon-alpha biosynthetic process(GO:0045356) |
0.1 | 0.6 | GO:0098719 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.1 | 1.1 | GO:0043551 | regulation of phosphatidylinositol 3-kinase activity(GO:0043551) |
0.1 | 1.0 | GO:0048753 | pigment granule organization(GO:0048753) |
0.1 | 0.2 | GO:0060406 | positive regulation of penile erection(GO:0060406) |
0.1 | 3.0 | GO:0010811 | positive regulation of cell-substrate adhesion(GO:0010811) |
0.1 | 0.5 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
0.1 | 0.9 | GO:0042491 | auditory receptor cell differentiation(GO:0042491) |
0.1 | 0.1 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
0.1 | 0.3 | GO:0045601 | regulation of endothelial cell differentiation(GO:0045601) |
0.1 | 0.2 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
0.1 | 0.4 | GO:0070307 | lens fiber cell development(GO:0070307) |
0.1 | 0.5 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
0.1 | 0.1 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.1 | 0.2 | GO:0033602 | negative regulation of dopamine secretion(GO:0033602) |
0.1 | 0.2 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
0.1 | 0.7 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.1 | 0.2 | GO:0060335 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
0.1 | 0.6 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.1 | 2.2 | GO:0035456 | response to interferon-beta(GO:0035456) |
0.1 | 1.0 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
0.1 | 0.3 | GO:0018406 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.1 | 0.2 | GO:0061092 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
0.1 | 0.3 | GO:0035635 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.1 | 0.3 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.1 | 0.3 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.1 | 1.2 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.1 | 0.4 | GO:0046697 | decidualization(GO:0046697) |
0.1 | 0.2 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.1 | 0.8 | GO:0022038 | corpus callosum development(GO:0022038) |
0.1 | 2.1 | GO:0030032 | lamellipodium assembly(GO:0030032) |
0.1 | 0.2 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.1 | 1.2 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.1 | 0.3 | GO:0097186 | amelogenesis(GO:0097186) |
0.1 | 0.5 | GO:0046629 | gamma-delta T cell activation(GO:0046629) |
0.1 | 1.8 | GO:0010761 | fibroblast migration(GO:0010761) |
0.1 | 0.2 | GO:0035994 | response to muscle stretch(GO:0035994) |
0.1 | 0.6 | GO:0034776 | response to histamine(GO:0034776) cellular response to histamine(GO:0071420) |
0.1 | 1.4 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.1 | 0.1 | GO:0086103 | G-protein coupled receptor signaling pathway involved in heart process(GO:0086103) |
0.1 | 0.1 | GO:0050711 | negative regulation of interleukin-1 secretion(GO:0050711) |
0.1 | 0.2 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
0.1 | 0.2 | GO:0090086 | negative regulation of protein deubiquitination(GO:0090086) |
0.1 | 0.4 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.1 | 0.2 | GO:0034214 | protein hexamerization(GO:0034214) |
0.1 | 1.0 | GO:1902230 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
0.1 | 0.1 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.1 | 0.3 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.1 | 0.5 | GO:0002467 | germinal center formation(GO:0002467) |
0.1 | 0.2 | GO:0097237 | cellular response to toxic substance(GO:0097237) |
0.1 | 0.1 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
0.1 | 0.5 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.1 | 0.1 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
0.1 | 0.2 | GO:0071694 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
0.1 | 0.4 | GO:0019348 | dolichol metabolic process(GO:0019348) |
0.1 | 0.1 | GO:2000668 | dendritic cell apoptotic process(GO:0097048) regulation of dendritic cell apoptotic process(GO:2000668) |
0.1 | 2.8 | GO:0030282 | bone mineralization(GO:0030282) |
0.1 | 0.1 | GO:0006868 | glutamine transport(GO:0006868) |
0.1 | 0.1 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
0.1 | 1.3 | GO:0006940 | regulation of smooth muscle contraction(GO:0006940) |
0.1 | 0.1 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.1 | 0.1 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) |
0.1 | 0.2 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.1 | 0.1 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
0.1 | 0.3 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
0.1 | 0.2 | GO:0000820 | regulation of glutamine family amino acid metabolic process(GO:0000820) |
0.1 | 0.1 | GO:0048069 | eye pigmentation(GO:0048069) |
0.1 | 0.6 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.1 | 0.2 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.1 | 0.1 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
0.1 | 0.4 | GO:0072538 | T-helper 17 type immune response(GO:0072538) |
0.1 | 0.2 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.1 | 0.4 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.1 | 0.2 | GO:0010166 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.1 | 0.1 | GO:1905208 | negative regulation of cardiocyte differentiation(GO:1905208) |
0.1 | 1.0 | GO:0007588 | excretion(GO:0007588) |
0.1 | 0.4 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.1 | 0.6 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
0.1 | 0.4 | GO:0006968 | cellular defense response(GO:0006968) |
0.1 | 0.3 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
0.1 | 0.1 | GO:0070562 | regulation of vitamin D receptor signaling pathway(GO:0070562) |
0.1 | 0.1 | GO:0051938 | L-glutamate import(GO:0051938) |
0.1 | 0.1 | GO:0032490 | detection of molecule of bacterial origin(GO:0032490) |
0.1 | 0.3 | GO:0070900 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.1 | 0.1 | GO:2001204 | regulation of osteoclast development(GO:2001204) |
0.1 | 1.1 | GO:0060612 | adipose tissue development(GO:0060612) |
0.1 | 0.3 | GO:0015867 | ATP transport(GO:0015867) |
0.1 | 0.2 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.1 | 0.3 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.1 | 0.5 | GO:0003323 | type B pancreatic cell development(GO:0003323) |
0.1 | 0.2 | GO:0036336 | dendritic cell migration(GO:0036336) |
0.1 | 0.1 | GO:1904180 | negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
0.1 | 0.1 | GO:0051895 | negative regulation of focal adhesion assembly(GO:0051895) |
0.1 | 0.1 | GO:1903514 | release of sequestered calcium ion into cytosol by sarcoplasmic reticulum(GO:0014808) calcium ion transport from endoplasmic reticulum to cytosol(GO:1903514) |
0.1 | 0.4 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.1 | 0.8 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.1 | 0.3 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.1 | 0.2 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.1 | 0.2 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
0.1 | 0.4 | GO:0042148 | strand invasion(GO:0042148) |
0.1 | 0.4 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.1 | 0.1 | GO:0061370 | testosterone biosynthetic process(GO:0061370) |
0.1 | 0.1 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
0.1 | 0.2 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.1 | 0.1 | GO:0034350 | regulation of glial cell apoptotic process(GO:0034350) |
0.1 | 0.2 | GO:0032788 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.1 | 0.4 | GO:0040036 | regulation of fibroblast growth factor receptor signaling pathway(GO:0040036) |
0.1 | 0.1 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.1 | 0.1 | GO:0071397 | cellular response to cholesterol(GO:0071397) |
0.1 | 0.4 | GO:0044068 | modulation by symbiont of host cellular process(GO:0044068) |
0.1 | 0.2 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.1 | 0.3 | GO:1902267 | polyamine transport(GO:0015846) polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) |
0.1 | 0.1 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
0.1 | 0.2 | GO:0010520 | regulation of reciprocal meiotic recombination(GO:0010520) |
0.1 | 0.2 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.1 | 0.2 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
0.1 | 0.1 | GO:0021943 | formation of radial glial scaffolds(GO:0021943) |
0.1 | 0.6 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.1 | 0.1 | GO:0060112 | generation of ovulation cycle rhythm(GO:0060112) |
0.1 | 0.3 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.1 | 0.2 | GO:0051798 | positive regulation of hair follicle development(GO:0051798) |
0.1 | 0.6 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
0.1 | 0.2 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.1 | 0.2 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
0.1 | 0.1 | GO:0003344 | pericardium morphogenesis(GO:0003344) |
0.1 | 0.2 | GO:1902254 | negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902254) |
0.1 | 0.3 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.1 | 0.1 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.1 | 0.2 | GO:0038030 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) |
0.1 | 0.2 | GO:0090188 | negative regulation of pancreatic juice secretion(GO:0090188) |
0.1 | 0.1 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
0.1 | 0.1 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.1 | 0.3 | GO:0015074 | DNA integration(GO:0015074) |
0.1 | 0.2 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.1 | 0.2 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.1 | 0.5 | GO:0055078 | sodium ion homeostasis(GO:0055078) |
0.1 | 0.1 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.1 | 0.2 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.1 | 0.1 | GO:0097210 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.0 | 0.1 | GO:1902475 | L-alpha-amino acid transmembrane transport(GO:1902475) |
0.0 | 3.6 | GO:0007266 | Rho protein signal transduction(GO:0007266) |
0.0 | 0.0 | GO:0051665 | membrane raft localization(GO:0051665) |
0.0 | 0.1 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
0.0 | 0.1 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.0 | 0.7 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.0 | 0.1 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.0 | 0.0 | GO:0046100 | hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
0.0 | 0.1 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.0 | 0.0 | GO:0001927 | exocyst assembly(GO:0001927) |
0.0 | 0.2 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.0 | 0.2 | GO:0034138 | toll-like receptor 3 signaling pathway(GO:0034138) |
0.0 | 0.2 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.0 | 0.3 | GO:0035510 | DNA dealkylation(GO:0035510) |
0.0 | 1.5 | GO:0035082 | axoneme assembly(GO:0035082) |
0.0 | 0.2 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.0 | 0.0 | GO:0045342 | MHC class II biosynthetic process(GO:0045342) |
0.0 | 0.1 | GO:0048302 | regulation of isotype switching to IgG isotypes(GO:0048302) |
0.0 | 0.9 | GO:2001238 | positive regulation of extrinsic apoptotic signaling pathway(GO:2001238) |
0.0 | 0.1 | GO:0035963 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.0 | 0.1 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.0 | 0.0 | GO:1903779 | regulation of cardiac conduction(GO:1903779) |
0.0 | 0.3 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.0 | 0.6 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.0 | 0.1 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.0 | 0.1 | GO:1901026 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.0 | 0.1 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
0.0 | 1.0 | GO:0031424 | keratinization(GO:0031424) |
0.0 | 0.0 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.0 | 0.2 | GO:0060384 | innervation(GO:0060384) |
0.0 | 0.1 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.0 | 0.2 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.0 | 0.5 | GO:1900003 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.0 | 0.1 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
0.0 | 0.5 | GO:0001913 | T cell mediated cytotoxicity(GO:0001913) |
0.0 | 1.4 | GO:0006941 | striated muscle contraction(GO:0006941) |
0.0 | 0.1 | GO:0071481 | cellular response to X-ray(GO:0071481) |
0.0 | 0.0 | GO:0008078 | mesodermal cell migration(GO:0008078) |
0.0 | 0.0 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.0 | 2.7 | GO:0008360 | regulation of cell shape(GO:0008360) |
0.0 | 0.0 | GO:0002677 | microglial cell activation involved in immune response(GO:0002282) negative regulation of chronic inflammatory response(GO:0002677) |
0.0 | 0.3 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
0.0 | 0.1 | GO:1990090 | response to nerve growth factor(GO:1990089) cellular response to nerve growth factor stimulus(GO:1990090) |
0.0 | 0.0 | GO:0045684 | positive regulation of epidermis development(GO:0045684) |
0.0 | 0.1 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
0.0 | 0.1 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.0 | 0.0 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
0.0 | 0.1 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.0 | 0.1 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
0.0 | 0.5 | GO:0072337 | modified amino acid transport(GO:0072337) |
0.0 | 0.1 | GO:0048478 | replication fork protection(GO:0048478) |
0.0 | 0.1 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
0.0 | 0.1 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
0.0 | 0.3 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.0 | 0.2 | GO:0048820 | hair follicle maturation(GO:0048820) |
0.0 | 0.1 | GO:0060026 | convergent extension(GO:0060026) |
0.0 | 0.5 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.0 | 0.1 | GO:0030202 | heparin metabolic process(GO:0030202) |
0.0 | 0.2 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.0 | 0.0 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) |
0.0 | 0.2 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.0 | 0.0 | GO:0010513 | positive regulation of phosphatidylinositol biosynthetic process(GO:0010513) |
0.0 | 0.2 | GO:0044273 | sulfur compound catabolic process(GO:0044273) |
0.0 | 0.1 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.0 | 0.1 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.0 | 0.0 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.0 | 0.0 | GO:0042747 | regulation of circadian sleep/wake cycle, REM sleep(GO:0042320) circadian sleep/wake cycle, REM sleep(GO:0042747) |
0.0 | 0.0 | GO:0070431 | nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
0.0 | 0.1 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.0 | 0.1 | GO:0010825 | positive regulation of centrosome duplication(GO:0010825) |
0.0 | 0.3 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.0 | 0.1 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.0 | 0.1 | GO:0035315 | hair cell differentiation(GO:0035315) |
0.0 | 0.1 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.0 | 0.0 | GO:2001182 | regulation of interleukin-12 secretion(GO:2001182) |
0.0 | 0.1 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.0 | 0.1 | GO:0009146 | purine nucleoside triphosphate catabolic process(GO:0009146) |
0.0 | 0.1 | GO:0060126 | somatotropin secreting cell differentiation(GO:0060126) |
0.0 | 0.1 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.0 | 0.4 | GO:0046834 | lipid phosphorylation(GO:0046834) |
0.0 | 0.0 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.0 | 0.3 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.0 | 0.2 | GO:1902624 | positive regulation of granulocyte chemotaxis(GO:0071624) positive regulation of neutrophil migration(GO:1902624) |
0.0 | 0.0 | GO:1901503 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) cellular lipid biosynthetic process(GO:0097384) ether biosynthetic process(GO:1901503) |
0.0 | 0.5 | GO:0006936 | muscle contraction(GO:0006936) |
0.0 | 0.1 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.0 | 0.0 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
0.0 | 0.2 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.0 | 0.2 | GO:0045103 | intermediate filament-based process(GO:0045103) |
0.0 | 0.3 | GO:0035904 | aorta development(GO:0035904) |
0.0 | 0.1 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
0.0 | 0.1 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.0 | 0.1 | GO:0071402 | cellular response to lipoprotein particle stimulus(GO:0071402) |
0.0 | 0.1 | GO:0071549 | response to dexamethasone(GO:0071548) cellular response to dexamethasone stimulus(GO:0071549) |
0.0 | 0.0 | GO:0014743 | regulation of muscle hypertrophy(GO:0014743) |
0.0 | 0.1 | GO:0071139 | resolution of recombination intermediates(GO:0071139) |
0.0 | 0.0 | GO:0006714 | sesquiterpenoid metabolic process(GO:0006714) |
0.0 | 0.0 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.0 | 0.0 | GO:0051799 | negative regulation of hair follicle development(GO:0051799) |
0.0 | 0.0 | GO:0044793 | negative regulation by host of viral process(GO:0044793) |
0.0 | 0.0 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.0 | 0.1 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.0 | 0.1 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.0 | 0.2 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.0 | 0.0 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.0 | 0.1 | GO:0019478 | D-amino acid catabolic process(GO:0019478) |
0.0 | 0.0 | GO:0034333 | adherens junction assembly(GO:0034333) |
0.0 | 0.1 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.0 | 0.3 | GO:0046580 | negative regulation of Ras protein signal transduction(GO:0046580) |
0.0 | 0.0 | GO:0001991 | regulation of systemic arterial blood pressure by circulatory renin-angiotensin(GO:0001991) |
0.0 | 0.0 | GO:0034143 | regulation of toll-like receptor 4 signaling pathway(GO:0034143) |
0.0 | 0.3 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.0 | 0.1 | GO:0071340 | skeletal muscle acetylcholine-gated channel clustering(GO:0071340) |
0.0 | 0.0 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.0 | 0.0 | GO:0003283 | atrial septum development(GO:0003283) |
0.0 | 0.0 | GO:0070885 | negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
0.0 | 0.1 | GO:0071265 | amino acid salvage(GO:0043102) L-methionine biosynthetic process(GO:0071265) L-methionine salvage(GO:0071267) |
0.0 | 0.1 | GO:0044351 | macropinocytosis(GO:0044351) |
0.0 | 0.1 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.0 | 0.1 | GO:0086009 | membrane repolarization(GO:0086009) |
0.0 | 0.1 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.0 | 0.1 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.0 | 0.1 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.0 | 0.0 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.0 | 0.0 | GO:0051181 | cofactor transport(GO:0051181) |
0.0 | 0.1 | GO:0051697 | protein delipidation(GO:0051697) |
0.0 | 0.0 | GO:0033240 | positive regulation of cellular amine metabolic process(GO:0033240) |
0.0 | 0.3 | GO:0010972 | negative regulation of G2/M transition of mitotic cell cycle(GO:0010972) |
0.0 | 0.1 | GO:0010737 | protein kinase A signaling(GO:0010737) |
0.0 | 0.1 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.0 | 0.0 | GO:0042758 | long-chain fatty acid catabolic process(GO:0042758) |
0.0 | 0.0 | GO:0060467 | negative regulation of fertilization(GO:0060467) |
0.0 | 0.0 | GO:0051409 | response to nitrosative stress(GO:0051409) |
0.0 | 0.0 | GO:0048539 | bone marrow development(GO:0048539) |
0.0 | 0.0 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.0 | 0.0 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
0.0 | 0.0 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.0 | 0.0 | GO:0006069 | ethanol metabolic process(GO:0006067) ethanol oxidation(GO:0006069) |
0.0 | 0.0 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.0 | 0.0 | GO:0051594 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.0 | 0.0 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.0 | 0.0 | GO:0045541 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.0 | 0.1 | GO:0010543 | regulation of platelet activation(GO:0010543) |
0.0 | 0.0 | GO:0002370 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
0.0 | 0.1 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) |
0.0 | 0.1 | GO:0014910 | regulation of smooth muscle cell migration(GO:0014910) |
0.0 | 0.0 | GO:0045823 | positive regulation of heart contraction(GO:0045823) |
0.0 | 0.0 | GO:0090324 | negative regulation of oxidative phosphorylation(GO:0090324) |
0.0 | 0.1 | GO:0052697 | xenobiotic glucuronidation(GO:0052697) |
0.0 | 0.0 | GO:0009174 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.3 | 6.9 | GO:0097512 | cardiac myofibril(GO:0097512) |
2.0 | 6.0 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
1.9 | 17.1 | GO:0005859 | muscle myosin complex(GO:0005859) |
1.7 | 8.6 | GO:0005927 | muscle tendon junction(GO:0005927) |
1.6 | 9.5 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
1.6 | 4.7 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
1.5 | 5.9 | GO:0030478 | actin cap(GO:0030478) |
1.4 | 4.3 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
1.3 | 10.7 | GO:0005861 | troponin complex(GO:0005861) |
1.2 | 6.1 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.9 | 3.6 | GO:0042567 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.9 | 3.5 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.8 | 11.5 | GO:0036379 | myofilament(GO:0036379) |
0.7 | 2.1 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.7 | 2.1 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.7 | 4.6 | GO:0045180 | basal cortex(GO:0045180) |
0.7 | 2.0 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.7 | 2.6 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.6 | 3.9 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.6 | 2.6 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.6 | 1.9 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.6 | 2.4 | GO:1990357 | terminal web(GO:1990357) |
0.6 | 6.6 | GO:0005916 | fascia adherens(GO:0005916) |
0.6 | 3.5 | GO:0098642 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.5 | 3.3 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.5 | 2.1 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.5 | 1.5 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.5 | 1.5 | GO:0032437 | cuticular plate(GO:0032437) |
0.5 | 1.0 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.5 | 4.0 | GO:0042587 | glycogen granule(GO:0042587) |
0.5 | 4.5 | GO:0020003 | symbiont-containing vacuole(GO:0020003) |
0.5 | 1.5 | GO:0048179 | activin receptor complex(GO:0048179) |
0.5 | 17.6 | GO:0014704 | intercalated disc(GO:0014704) |
0.5 | 8.2 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.5 | 0.9 | GO:0043259 | laminin-10 complex(GO:0043259) |
0.5 | 6.1 | GO:0043034 | costamere(GO:0043034) |
0.5 | 1.4 | GO:0097443 | sorting endosome(GO:0097443) |
0.4 | 2.2 | GO:0005915 | zonula adherens(GO:0005915) |
0.4 | 2.6 | GO:0043219 | lateral loop(GO:0043219) |
0.4 | 0.4 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.4 | 6.8 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.4 | 1.7 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.4 | 1.7 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.4 | 2.5 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.4 | 22.7 | GO:0030018 | Z disc(GO:0030018) |
0.4 | 1.2 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.4 | 4.4 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.4 | 0.8 | GO:0043256 | laminin complex(GO:0043256) |
0.4 | 3.6 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.4 | 1.6 | GO:0071953 | elastic fiber(GO:0071953) |
0.4 | 1.5 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.4 | 30.6 | GO:0005604 | basement membrane(GO:0005604) |
0.4 | 1.1 | GO:0043511 | inhibin complex(GO:0043511) |
0.4 | 1.4 | GO:0031430 | M band(GO:0031430) |
0.3 | 3.1 | GO:0001527 | microfibril(GO:0001527) |
0.3 | 2.0 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.3 | 13.1 | GO:0030016 | myofibril(GO:0030016) |
0.3 | 1.2 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.3 | 0.9 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.3 | 11.1 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.3 | 2.1 | GO:0090543 | Flemming body(GO:0090543) |
0.3 | 1.5 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.3 | 1.5 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.3 | 11.8 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.3 | 13.6 | GO:0005581 | collagen trimer(GO:0005581) |
0.3 | 1.3 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.3 | 4.0 | GO:0030057 | desmosome(GO:0030057) |
0.2 | 1.5 | GO:0031983 | vesicle lumen(GO:0031983) |
0.2 | 0.2 | GO:0030056 | hemidesmosome(GO:0030056) |
0.2 | 1.0 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.2 | 0.5 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.2 | 0.7 | GO:1990393 | 3M complex(GO:1990393) |
0.2 | 1.4 | GO:0097342 | ripoptosome(GO:0097342) |
0.2 | 2.3 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
0.2 | 2.5 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.2 | 5.1 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.2 | 2.0 | GO:0060091 | kinocilium(GO:0060091) |
0.2 | 0.4 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
0.2 | 0.6 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.2 | 0.8 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.2 | 0.4 | GO:0031523 | Myb complex(GO:0031523) |
0.2 | 1.3 | GO:0071546 | pi-body(GO:0071546) |
0.2 | 3.7 | GO:0030315 | T-tubule(GO:0030315) |
0.2 | 0.9 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.2 | 0.4 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.2 | 0.7 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.2 | 1.2 | GO:0097470 | ribbon synapse(GO:0097470) |
0.2 | 1.6 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.2 | 0.9 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.2 | 1.2 | GO:0043220 | Schmidt-Lanterman incisure(GO:0043220) |
0.2 | 7.2 | GO:0042383 | sarcolemma(GO:0042383) |
0.2 | 0.5 | GO:0045251 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.2 | 1.9 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.2 | 0.5 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.2 | 36.1 | GO:0031012 | extracellular matrix(GO:0031012) |
0.2 | 0.3 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.2 | 0.5 | GO:0043293 | apoptosome(GO:0043293) |
0.2 | 1.4 | GO:0036156 | inner dynein arm(GO:0036156) |
0.2 | 0.5 | GO:1990635 | proximal dendrite(GO:1990635) |
0.1 | 0.1 | GO:0044393 | microspike(GO:0044393) |
0.1 | 0.6 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.1 | 1.2 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.1 | 0.5 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.1 | 0.4 | GO:0032280 | symmetric synapse(GO:0032280) |
0.1 | 0.8 | GO:0033270 | paranode region of axon(GO:0033270) |
0.1 | 0.9 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.1 | 0.6 | GO:0044214 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.1 | 0.4 | GO:0097441 | basilar dendrite(GO:0097441) |
0.1 | 0.4 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.1 | 1.0 | GO:0097542 | ciliary tip(GO:0097542) |
0.1 | 1.0 | GO:0031143 | pseudopodium(GO:0031143) |
0.1 | 0.5 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.1 | 0.5 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
0.1 | 0.2 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.1 | 2.3 | GO:0008305 | integrin complex(GO:0008305) |
0.1 | 0.5 | GO:0032982 | myosin filament(GO:0032982) |
0.1 | 6.1 | GO:0005901 | caveola(GO:0005901) |
0.1 | 0.9 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.1 | 2.4 | GO:0001772 | immunological synapse(GO:0001772) |
0.1 | 2.0 | GO:0005922 | connexon complex(GO:0005922) |
0.1 | 9.2 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.1 | 0.4 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.1 | 8.6 | GO:0043296 | apical junction complex(GO:0043296) |
0.1 | 0.7 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.1 | 0.9 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.1 | 0.7 | GO:0034464 | BBSome(GO:0034464) |
0.1 | 0.6 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.1 | 0.3 | GO:0045298 | tubulin complex(GO:0045298) |
0.1 | 0.3 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.1 | 0.5 | GO:0042641 | actomyosin(GO:0042641) |
0.1 | 0.2 | GO:0045277 | respiratory chain complex IV(GO:0045277) |
0.1 | 0.4 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.1 | 0.3 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.1 | 3.2 | GO:0045095 | keratin filament(GO:0045095) |
0.1 | 0.2 | GO:0071203 | WASH complex(GO:0071203) |
0.1 | 2.5 | GO:0032420 | stereocilium(GO:0032420) |
0.1 | 0.3 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.1 | 0.8 | GO:0016580 | Sin3 complex(GO:0016580) |
0.1 | 4.5 | GO:0005811 | lipid particle(GO:0005811) |
0.1 | 0.2 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.1 | 0.6 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.1 | 0.2 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
0.1 | 16.7 | GO:0005925 | focal adhesion(GO:0005925) |
0.1 | 0.2 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.1 | 0.3 | GO:1990246 | uniplex complex(GO:1990246) |
0.1 | 0.4 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.1 | 0.4 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.1 | 0.9 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.1 | 19.8 | GO:0005667 | transcription factor complex(GO:0005667) |
0.1 | 0.5 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.1 | 0.9 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.1 | 0.3 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.0 | 0.0 | GO:0044326 | dendritic spine neck(GO:0044326) |
0.0 | 0.2 | GO:0072487 | MSL complex(GO:0072487) |
0.0 | 0.7 | GO:0046930 | pore complex(GO:0046930) |
0.0 | 0.1 | GO:0005767 | secondary lysosome(GO:0005767) |
0.0 | 0.7 | GO:1902711 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.0 | 0.5 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.0 | 0.0 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.0 | 0.2 | GO:0016589 | NURF complex(GO:0016589) |
0.0 | 0.4 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.0 | 0.1 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.0 | 0.3 | GO:0097225 | sperm midpiece(GO:0097225) |
0.0 | 0.1 | GO:0044299 | C-fiber(GO:0044299) |
0.0 | 0.3 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.0 | 0.1 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.0 | 0.0 | GO:0016460 | myosin II complex(GO:0016460) |
0.0 | 0.1 | GO:0042583 | chromaffin granule(GO:0042583) |
0.0 | 0.5 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.0 | 1.7 | GO:0001726 | ruffle(GO:0001726) |
0.0 | 0.2 | GO:0045263 | proton-transporting ATP synthase complex, coupling factor F(o)(GO:0045263) |
0.0 | 0.1 | GO:0018995 | host(GO:0018995) host cell part(GO:0033643) host cell(GO:0043657) |
0.0 | 1.5 | GO:0016605 | PML body(GO:0016605) |
0.0 | 0.2 | GO:0097440 | apical dendrite(GO:0097440) |
0.0 | 0.1 | GO:0035838 | growing cell tip(GO:0035838) |
0.0 | 0.3 | GO:0000242 | pericentriolar material(GO:0000242) |
0.0 | 0.1 | GO:0071547 | piP-body(GO:0071547) |
0.0 | 0.1 | GO:0001520 | outer dense fiber(GO:0001520) |
0.0 | 0.0 | GO:1990696 | USH2 complex(GO:1990696) |
0.0 | 0.1 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.0 | 0.1 | GO:0033391 | chromatoid body(GO:0033391) |
0.0 | 0.1 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.0 | 0.1 | GO:0005827 | polar microtubule(GO:0005827) |
0.0 | 0.0 | GO:0000802 | transverse filament(GO:0000802) |
0.0 | 0.2 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.0 | 0.1 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.0 | 0.0 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.0 | 0.0 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.0 | 0.1 | GO:0017059 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.0 | 0.1 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.5 | 14.1 | GO:0031433 | telethonin binding(GO:0031433) |
2.5 | 9.8 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) |
1.7 | 3.5 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
1.6 | 11.3 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
1.6 | 4.8 | GO:0030172 | troponin C binding(GO:0030172) |
1.5 | 10.7 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
1.5 | 4.5 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
1.4 | 2.9 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
1.3 | 6.5 | GO:0051525 | NFAT protein binding(GO:0051525) |
1.3 | 3.9 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
1.3 | 6.5 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
1.3 | 3.9 | GO:0031014 | troponin T binding(GO:0031014) |
1.3 | 5.1 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
1.2 | 3.7 | GO:0035939 | microsatellite binding(GO:0035939) |
1.2 | 3.7 | GO:0051373 | FATZ binding(GO:0051373) |
1.2 | 3.6 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
1.2 | 3.5 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
1.0 | 4.2 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
1.0 | 6.2 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
1.0 | 3.0 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
1.0 | 5.8 | GO:0034889 | alkyl sulfatase activity(GO:0018741) endosulfan hemisulfate sulfatase activity(GO:0034889) endosulfan sulfate hydrolase activity(GO:0034902) |
1.0 | 8.6 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.9 | 0.9 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
0.9 | 5.3 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
0.9 | 3.5 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.9 | 1.7 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.8 | 2.4 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.8 | 2.4 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.8 | 17.4 | GO:0042805 | actinin binding(GO:0042805) |
0.7 | 3.7 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.7 | 2.2 | GO:2001070 | starch binding(GO:2001070) |
0.7 | 2.2 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.7 | 2.2 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.7 | 2.1 | GO:0070538 | oleic acid binding(GO:0070538) |
0.7 | 2.8 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.7 | 2.7 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.7 | 7.9 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.6 | 3.2 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.6 | 1.9 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.6 | 3.2 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.6 | 8.3 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.6 | 5.7 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.6 | 2.5 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.6 | 3.0 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.6 | 1.2 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.6 | 1.2 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.6 | 3.6 | GO:0031432 | titin binding(GO:0031432) |
0.6 | 1.7 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.5 | 3.3 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.5 | 2.1 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.5 | 2.1 | GO:0070052 | collagen V binding(GO:0070052) |
0.5 | 3.1 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.5 | 4.6 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.5 | 3.1 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
0.5 | 2.0 | GO:0035276 | ethanol binding(GO:0035276) |
0.5 | 4.0 | GO:0017166 | vinculin binding(GO:0017166) |
0.5 | 2.4 | GO:1990254 | keratin filament binding(GO:1990254) |
0.5 | 4.3 | GO:0044548 | S100 protein binding(GO:0044548) |
0.5 | 0.5 | GO:0031013 | troponin I binding(GO:0031013) |
0.5 | 0.9 | GO:0000828 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.4 | 0.4 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.4 | 3.5 | GO:0038191 | neuropilin binding(GO:0038191) |
0.4 | 4.7 | GO:0030552 | cAMP binding(GO:0030552) |
0.4 | 4.2 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.4 | 1.2 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
0.4 | 2.0 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.4 | 1.6 | GO:0043515 | kinetochore binding(GO:0043515) |
0.4 | 10.0 | GO:0052712 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) photoreceptor cyclic-nucleotide phosphodiesterase activity(GO:0004120) 7,8-dihydro-D-neopterin 2',3'-cyclic phosphate phosphodiesterase activity(GO:0044688) inositol phosphosphingolipid phospholipase activity(GO:0052712) inositol phosphorylceramide phospholipase activity(GO:0052713) mannosyl-inositol phosphorylceramide phospholipase activity(GO:0052714) mannosyl-diinositol phosphorylceramide phospholipase activity(GO:0052715) |
0.4 | 0.8 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.4 | 4.8 | GO:0031078 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.4 | 2.8 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.4 | 1.2 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
0.4 | 13.6 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.4 | 1.2 | GO:0008142 | oxysterol binding(GO:0008142) |
0.4 | 1.5 | GO:0042731 | PH domain binding(GO:0042731) |
0.4 | 1.1 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.4 | 1.5 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.4 | 1.8 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.4 | 1.8 | GO:0043426 | MRF binding(GO:0043426) |
0.4 | 7.0 | GO:0003785 | actin monomer binding(GO:0003785) |
0.4 | 2.2 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.4 | 1.1 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.4 | 1.1 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.4 | 1.1 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.4 | 2.1 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.4 | 0.7 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.4 | 0.4 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.4 | 1.4 | GO:0071253 | connexin binding(GO:0071253) |
0.3 | 1.4 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.3 | 1.0 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.3 | 1.0 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.3 | 1.4 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.3 | 1.7 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.3 | 2.0 | GO:0070191 | methionine-R-sulfoxide reductase activity(GO:0070191) |
0.3 | 2.0 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.3 | 4.0 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.3 | 2.0 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.3 | 1.0 | GO:0043199 | sulfate binding(GO:0043199) |
0.3 | 1.6 | GO:0017040 | ceramidase activity(GO:0017040) |
0.3 | 1.3 | GO:0034584 | piRNA binding(GO:0034584) |
0.3 | 0.6 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.3 | 1.9 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.3 | 1.0 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.3 | 0.6 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.3 | 0.6 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.3 | 4.1 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.3 | 1.2 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.3 | 0.9 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.3 | 0.9 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.3 | 2.7 | GO:0015922 | aspartate oxidase activity(GO:0015922) |
0.3 | 3.3 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.3 | 0.9 | GO:0016649 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.3 | 0.9 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.3 | 2.7 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.3 | 8.8 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.3 | 0.9 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.3 | 2.0 | GO:0018646 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
0.3 | 3.4 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
0.3 | 3.9 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.3 | 0.8 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.3 | 0.8 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.3 | 0.6 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.3 | 1.1 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.3 | 3.5 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.3 | 1.9 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.3 | 0.8 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.3 | 1.1 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.3 | 0.8 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.3 | 0.8 | GO:0023029 | MHC class Ib protein binding(GO:0023029) |
0.3 | 0.8 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
0.3 | 0.5 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.3 | 1.6 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.3 | 1.6 | GO:0045545 | syndecan binding(GO:0045545) |
0.3 | 1.3 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.3 | 1.3 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.3 | 0.8 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.3 | 0.8 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.3 | 0.5 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.3 | 5.5 | GO:0045296 | cadherin binding(GO:0045296) |
0.3 | 1.3 | GO:0034711 | inhibin binding(GO:0034711) |
0.2 | 0.7 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.2 | 0.7 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.2 | 1.2 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.2 | 0.7 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
0.2 | 1.7 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.2 | 2.9 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.2 | 0.5 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.2 | 1.4 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.2 | 2.8 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.2 | 2.6 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.2 | 0.9 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.2 | 1.4 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.2 | 1.2 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.2 | 3.0 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.2 | 1.2 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.2 | 1.1 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.2 | 1.6 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.2 | 0.7 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.2 | 0.7 | GO:0048185 | activin binding(GO:0048185) |
0.2 | 1.1 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.2 | 2.0 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.2 | 1.3 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.2 | 2.4 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.2 | 1.3 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.2 | 0.9 | GO:0003840 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
0.2 | 1.1 | GO:0019958 | C-X-C chemokine binding(GO:0019958) |
0.2 | 0.2 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.2 | 0.9 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.2 | 17.8 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.2 | 1.2 | GO:0050700 | CARD domain binding(GO:0050700) |
0.2 | 3.3 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.2 | 0.2 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.2 | 11.1 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.2 | 0.6 | GO:0051425 | PTB domain binding(GO:0051425) |
0.2 | 2.4 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.2 | 0.2 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.2 | 1.2 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.2 | 0.6 | GO:0004471 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) |
0.2 | 0.4 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.2 | 0.6 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.2 | 2.8 | GO:0030291 | protein serine/threonine kinase inhibitor activity(GO:0030291) |
0.2 | 0.8 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.2 | 1.4 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.2 | 0.8 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.2 | 2.3 | GO:0005536 | glucose binding(GO:0005536) |
0.2 | 0.4 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.2 | 0.8 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.2 | 1.7 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.2 | 2.6 | GO:0008143 | poly(A) binding(GO:0008143) |
0.2 | 0.7 | GO:0030274 | LIM domain binding(GO:0030274) |
0.2 | 0.6 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.2 | 3.0 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.2 | 0.4 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.2 | 0.4 | GO:0004096 | catalase activity(GO:0004096) |
0.2 | 0.4 | GO:0030984 | kininogen binding(GO:0030984) |
0.2 | 0.4 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.2 | 0.5 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.2 | 3.2 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.2 | 0.2 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.2 | 0.2 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.2 | 0.5 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
0.2 | 1.2 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.2 | 0.7 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.2 | 0.5 | GO:0048030 | disaccharide binding(GO:0048030) |
0.2 | 0.3 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.2 | 2.1 | GO:0001846 | opsonin binding(GO:0001846) |
0.2 | 0.5 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.2 | 1.7 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.2 | 1.0 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.2 | 0.3 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.2 | 2.2 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.2 | 1.7 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.2 | 1.8 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.2 | 0.7 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.2 | 8.3 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.2 | 1.5 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.2 | 2.5 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.2 | 0.8 | GO:0002054 | nucleobase binding(GO:0002054) |
0.2 | 0.5 | GO:0015065 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.2 | 0.6 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.2 | 0.5 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
0.2 | 0.8 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.2 | 0.5 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.2 | 0.6 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.2 | 5.8 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.2 | 0.8 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.2 | 1.9 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.2 | 0.3 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.2 | 1.2 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.2 | 0.9 | GO:0034912 | enoyl-[acyl-carrier-protein] reductase activity(GO:0016631) 2,3-dihydroxy-2,3-dihydro-phenylpropionate dehydrogenase activity(GO:0018498) cis-2,3-dihydrodiol DDT dehydrogenase activity(GO:0018499) trans-9R,10R-dihydrodiolphenanthrene dehydrogenase activity(GO:0018500) cis-chlorobenzene dihydrodiol dehydrogenase activity(GO:0018501) 2,5-dichloro-2,5-cyclohexadiene-1,4-diol dehydrogenase activity(GO:0018502) trans-1,2-dihydrodiolphenanthrene dehydrogenase activity(GO:0018503) 3,4-dihydroxy-3,4-dihydrofluorene dehydrogenase activity(GO:0034790) benzo(a)pyrene-trans-11,12-dihydrodiol dehydrogenase activity(GO:0034805) benzo(a)pyrene-cis-4,5-dihydrodiol dehydrogenase activity(GO:0034809) citronellyl-CoA dehydrogenase activity(GO:0034824) menthone dehydrogenase activity(GO:0034838) phthalate 3,4-cis-dihydrodiol dehydrogenase activity(GO:0034912) cinnamate reductase activity(GO:0043786) NADPH-dependent curcumin reductase activity(GO:0052849) NADPH-dependent dihydrocurcumin reductase activity(GO:0052850) |
0.1 | 3.3 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.1 | 0.7 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.1 | 0.1 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
0.1 | 1.0 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.1 | 2.9 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.1 | 1.0 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.1 | 0.3 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.1 | 2.0 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.1 | 0.7 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.1 | 37.6 | GO:0003779 | actin binding(GO:0003779) |
0.1 | 0.4 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.1 | 0.3 | GO:0051430 | corticotropin-releasing hormone receptor 1 binding(GO:0051430) |
0.1 | 0.1 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.1 | 3.2 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.1 | 0.6 | GO:0043829 | N-cyclopropylmelamine deaminase activity(GO:0034547) N-cyclopropylammeline deaminase activity(GO:0034548) N-cyclopropylammelide alkylamino hydrolase activity(GO:0034549) 2,5-diamino-6-ribitylamino-4(3H)-pyrimidinone 5'-phosphate deaminase activity(GO:0043723) tRNA-specific adenosine-37 deaminase activity(GO:0043829) archaeal-specific GTP cyclohydrolase activity(GO:0044682) tRNA-specific adenosine-34 deaminase activity(GO:0052717) |
0.1 | 0.4 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.1 | 0.4 | GO:0004359 | glutaminase activity(GO:0004359) |
0.1 | 0.4 | GO:0035514 | DNA demethylase activity(GO:0035514) |
0.1 | 2.1 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.1 | 0.4 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.1 | 0.6 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.1 | 0.5 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.1 | 0.4 | GO:0008107 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.1 | 1.7 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.1 | 1.6 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.1 | 3.8 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.1 | 0.4 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.1 | 7.7 | GO:0008083 | growth factor activity(GO:0008083) |
0.1 | 2.0 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.1 | 0.2 | GO:0004673 | protein histidine kinase activity(GO:0004673) |
0.1 | 0.2 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.1 | 0.9 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.1 | 0.4 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
0.1 | 0.5 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.1 | 4.7 | GO:0001191 | transcriptional repressor activity, RNA polymerase II transcription factor binding(GO:0001191) |
0.1 | 3.1 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.1 | 0.3 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
0.1 | 0.3 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.1 | 3.4 | GO:0004180 | carboxypeptidase activity(GO:0004180) |
0.1 | 0.7 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.1 | 0.7 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
0.1 | 1.2 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.1 | 0.3 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.1 | 2.1 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.1 | 1.2 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.1 | 3.4 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.1 | 0.3 | GO:0036033 | mediator complex binding(GO:0036033) |
0.1 | 0.4 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.1 | 0.4 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.1 | 0.4 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.1 | 0.5 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.1 | 0.1 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
0.1 | 0.3 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
0.1 | 0.7 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.1 | 0.3 | GO:0035473 | lipase binding(GO:0035473) |
0.1 | 0.7 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.1 | 1.1 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.1 | 0.5 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.1 | 2.1 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
0.1 | 0.5 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
0.1 | 2.5 | GO:0005518 | collagen binding(GO:0005518) |
0.1 | 1.4 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.1 | 1.0 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.1 | 0.4 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
0.1 | 1.0 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.1 | 0.2 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.1 | 0.2 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.1 | 2.6 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.1 | 2.8 | GO:0005109 | frizzled binding(GO:0005109) |
0.1 | 0.3 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.1 | 0.5 | GO:0000150 | recombinase activity(GO:0000150) |
0.1 | 0.3 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.1 | 0.3 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.1 | 0.3 | GO:0004031 | aldehyde oxidase activity(GO:0004031) oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
0.1 | 0.4 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.1 | 0.2 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
0.1 | 0.4 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.1 | 0.3 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.1 | 4.6 | GO:0005178 | integrin binding(GO:0005178) |
0.1 | 0.3 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.1 | 0.8 | GO:0034841 | 3-oxo-2-(2'-pentenyl)cyclopentane-1-octanoic acid CoA ligase activity(GO:0010435) 3-isopropenyl-6-oxoheptanoyl-CoA synthetase activity(GO:0018854) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA synthetase activity(GO:0018855) benzoyl acetate-CoA ligase activity(GO:0018856) 2,4-dichlorobenzoate-CoA ligase activity(GO:0018857) pivalate-CoA ligase activity(GO:0034783) cyclopropanecarboxylate-CoA ligase activity(GO:0034793) adipate-CoA ligase activity(GO:0034796) citronellyl-CoA ligase activity(GO:0034823) mentha-1,3-dione-CoA ligase activity(GO:0034841) thiophene-2-carboxylate-CoA ligase activity(GO:0034842) 2,4,4-trimethylpentanoate-CoA ligase activity(GO:0034865) cis-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034942) trans-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034943) branched-chain acyl-CoA synthetase (ADP-forming) activity(GO:0043759) aryl-CoA synthetase (ADP-forming) activity(GO:0043762) 3-hydroxypropionyl-CoA synthetase activity(GO:0043955) perillic acid:CoA ligase (ADP-forming) activity(GO:0052685) perillic acid:CoA ligase (AMP-forming) activity(GO:0052686) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (ADP-forming) activity(GO:0052687) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (AMP-forming) activity(GO:0052688) pristanate-CoA ligase activity(GO:0070251) malonyl-CoA synthetase activity(GO:0090409) |
0.1 | 2.0 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.1 | 0.4 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.1 | 0.2 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.1 | 0.3 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) |
0.1 | 0.2 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.1 | 0.9 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.1 | 0.3 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.1 | 0.5 | GO:0035591 | signaling adaptor activity(GO:0035591) |
0.1 | 0.2 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.1 | 0.2 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.1 | 0.6 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.1 | 0.1 | GO:0015186 | L-asparagine transmembrane transporter activity(GO:0015182) L-glutamine transmembrane transporter activity(GO:0015186) |
0.1 | 1.7 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.1 | 0.8 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.1 | 0.1 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.1 | 0.4 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.1 | 0.4 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.1 | 0.2 | GO:0005347 | ATP transmembrane transporter activity(GO:0005347) |
0.1 | 0.5 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.1 | 0.3 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.1 | 0.2 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.1 | 0.1 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.1 | 1.0 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.1 | 0.4 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.1 | 0.2 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.1 | 0.6 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.1 | 0.2 | GO:0005522 | profilin binding(GO:0005522) |
0.1 | 0.3 | GO:0031419 | cobalamin binding(GO:0031419) |
0.1 | 0.3 | GO:0071614 | linoleic acid epoxygenase activity(GO:0071614) |
0.1 | 2.3 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.1 | 0.2 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.1 | 0.2 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.1 | 0.5 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.1 | 1.1 | GO:0019152 | C-3 sterol dehydrogenase (C-4 sterol decarboxylase) activity(GO:0000252) mevaldate reductase activity(GO:0004495) gluconate dehydrogenase activity(GO:0008875) epoxide dehydrogenase activity(GO:0018451) 5-exo-hydroxycamphor dehydrogenase activity(GO:0018452) 2-hydroxytetrahydrofuran dehydrogenase activity(GO:0018453) acetoin dehydrogenase activity(GO:0019152) phenylcoumaran benzylic ether reductase activity(GO:0032442) D-xylose:NADP reductase activity(GO:0032866) L-arabinose:NADP reductase activity(GO:0032867) D-arabinitol dehydrogenase, D-ribulose forming (NADP+) activity(GO:0033709) (R)-(-)-1,2,3,4-tetrahydronaphthol dehydrogenase activity(GO:0034831) 3-hydroxymenthone dehydrogenase activity(GO:0034840) very long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0035380) dihydrotestosterone 17-beta-dehydrogenase activity(GO:0035410) (R)-2-hydroxyisocaproate dehydrogenase activity(GO:0043713) L-arabinose 1-dehydrogenase (NADP+) activity(GO:0044103) L-xylulose reductase (NAD+) activity(GO:0044105) 3-ketoglucose-reductase activity(GO:0048258) D-arabinitol dehydrogenase, D-xylulose forming (NADP+) activity(GO:0052677) |
0.1 | 0.2 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
0.1 | 5.5 | GO:0005539 | glycosaminoglycan binding(GO:0005539) |
0.1 | 0.3 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.1 | 0.4 | GO:0004738 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
0.1 | 0.4 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.1 | 0.2 | GO:0035877 | death effector domain binding(GO:0035877) |
0.1 | 0.3 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
0.1 | 1.0 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.1 | 0.7 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.1 | 0.2 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.1 | 0.6 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.1 | 0.1 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.1 | 0.6 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.1 | 0.2 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
0.1 | 0.3 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.1 | 0.3 | GO:0004331 | fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.1 | 0.2 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
0.1 | 0.5 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.1 | 0.2 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.1 | 0.3 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.1 | 0.2 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.1 | 0.2 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.1 | 0.1 | GO:0003933 | GTP cyclohydrolase activity(GO:0003933) |
0.1 | 0.3 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.1 | 1.3 | GO:0034594 | phosphatidylinositol trisphosphate phosphatase activity(GO:0034594) |
0.1 | 0.1 | GO:0001226 | RNA polymerase II transcription corepressor binding(GO:0001226) |
0.1 | 0.3 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.1 | 0.5 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.1 | 0.3 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.1 | 0.1 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.1 | 0.3 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.1 | 0.3 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.1 | 0.1 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.1 | 0.1 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.1 | 0.8 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.0 | 0.0 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.0 | 0.2 | GO:0102345 | 3-hydroxy-behenoyl-CoA dehydratase activity(GO:0102344) 3-hydroxy-lignoceroyl-CoA dehydratase activity(GO:0102345) |
0.0 | 1.0 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.0 | 0.1 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
0.0 | 0.5 | GO:0051400 | BH domain binding(GO:0051400) |
0.0 | 0.1 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.0 | 0.0 | GO:0031705 | bombesin receptor binding(GO:0031705) |
0.0 | 0.4 | GO:0030955 | potassium ion binding(GO:0030955) |
0.0 | 0.0 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.0 | 0.3 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
0.0 | 0.0 | GO:0070546 | L-phenylalanine aminotransferase activity(GO:0070546) L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
0.0 | 0.1 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.0 | 7.3 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.0 | 0.5 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.0 | 0.4 | GO:0005451 | monovalent cation:proton antiporter activity(GO:0005451) |
0.0 | 0.3 | GO:0005123 | death receptor binding(GO:0005123) |
0.0 | 0.0 | GO:0032551 | UTP binding(GO:0002134) pyrimidine ribonucleoside binding(GO:0032551) |
0.0 | 0.0 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.0 | 0.8 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.0 | 0.2 | GO:1990459 | transferrin receptor binding(GO:1990459) |
0.0 | 0.3 | GO:1901682 | sulfur compound transmembrane transporter activity(GO:1901682) |
0.0 | 0.2 | GO:0015288 | porin activity(GO:0015288) |
0.0 | 0.0 | GO:0004950 | G-protein coupled chemoattractant receptor activity(GO:0001637) chemokine receptor activity(GO:0004950) |
0.0 | 0.9 | GO:0008009 | chemokine activity(GO:0008009) |
0.0 | 0.3 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.0 | 0.1 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.0 | 0.0 | GO:0034593 | phosphatidylinositol bisphosphate phosphatase activity(GO:0034593) |
0.0 | 0.1 | GO:0002046 | opsin binding(GO:0002046) |
0.0 | 0.1 | GO:0003865 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.0 | 0.1 | GO:0032052 | bile acid binding(GO:0032052) |
0.0 | 0.0 | GO:0050051 | leukotriene-B4 20-monooxygenase activity(GO:0050051) |
0.0 | 3.3 | GO:0008237 | metallopeptidase activity(GO:0008237) |
0.0 | 0.1 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.0 | 0.4 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
0.0 | 0.5 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.0 | 1.9 | GO:0044325 | ion channel binding(GO:0044325) |
0.0 | 0.2 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.0 | 1.3 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.0 | 0.1 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.0 | 0.5 | GO:0015464 | acetylcholine receptor activity(GO:0015464) |
0.0 | 0.1 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.0 | 0.1 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.0 | 0.0 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.0 | 0.1 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.0 | 0.5 | GO:0004129 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.0 | 0.1 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.0 | 0.3 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.0 | 0.0 | GO:0030519 | snoRNP binding(GO:0030519) |
0.0 | 0.3 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.0 | 0.1 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.0 | 1.3 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.0 | 0.0 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.0 | 0.0 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.0 | 0.2 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
0.0 | 0.3 | GO:0043295 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.0 | 0.0 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
0.0 | 0.4 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.0 | 0.0 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.0 | 0.1 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.0 | 0.0 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.0 | 0.0 | GO:0038100 | nodal binding(GO:0038100) |
0.0 | 0.0 | GO:0034191 | apolipoprotein A-I receptor binding(GO:0034191) |
0.0 | 0.1 | GO:0070513 | death domain binding(GO:0070513) |
0.0 | 0.0 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.0 | 0.1 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
0.0 | 0.3 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.0 | 1.4 | GO:0004721 | phosphoprotein phosphatase activity(GO:0004721) |
0.0 | 0.0 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.0 | 0.1 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.0 | 0.1 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.0 | 0.1 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.0 | 0.1 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.0 | 0.0 | GO:0015299 | solute:proton antiporter activity(GO:0015299) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 6.0 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.5 | 2.0 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.5 | 0.5 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.5 | 13.5 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.4 | 6.3 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.4 | 7.6 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.4 | 2.0 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.4 | 11.3 | NABA COLLAGENS | Genes encoding collagen proteins |
0.4 | 8.6 | PID ALK1 PATHWAY | ALK1 signaling events |
0.4 | 16.5 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.4 | 8.9 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.4 | 12.7 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.3 | 2.4 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.3 | 15.2 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.3 | 2.7 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.3 | 4.7 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.3 | 2.0 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.3 | 8.7 | PID RAS PATHWAY | Regulation of Ras family activation |
0.3 | 2.3 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.3 | 13.8 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.3 | 7.6 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.3 | 10.6 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.3 | 1.5 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.3 | 5.8 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.3 | 10.3 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.3 | 4.0 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.3 | 2.6 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.3 | 1.6 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.3 | 0.5 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.3 | 2.8 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.3 | 3.3 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.3 | 4.3 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.2 | 36.9 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.2 | 8.2 | NABA CORE MATRISOME | Ensemble of genes encoding core extracellular matrix including ECM glycoproteins, collagens and proteoglycans |
0.2 | 4.6 | PID INSULIN PATHWAY | Insulin Pathway |
0.2 | 3.0 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.2 | 11.2 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.2 | 5.4 | PID FGF PATHWAY | FGF signaling pathway |
0.2 | 2.9 | PID ENDOTHELIN PATHWAY | Endothelins |
0.2 | 0.8 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.2 | 2.7 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.2 | 4.9 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.2 | 0.2 | ST ADRENERGIC | Adrenergic Pathway |
0.2 | 0.2 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.2 | 0.6 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.2 | 0.8 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.2 | 1.5 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.2 | 0.9 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.2 | 3.1 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.2 | 24.0 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.2 | 3.4 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.2 | 4.4 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.2 | 7.7 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.2 | 0.9 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.2 | 0.8 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.2 | 0.5 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 1.0 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.1 | 0.9 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.1 | 0.1 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.1 | 1.0 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.1 | 2.0 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.1 | 0.1 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.1 | 2.3 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.1 | 2.6 | PID BMP PATHWAY | BMP receptor signaling |
0.1 | 1.3 | PID SHP2 PATHWAY | SHP2 signaling |
0.1 | 2.8 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.1 | 2.7 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.1 | 1.9 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.1 | 1.2 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.1 | 1.6 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.1 | 0.9 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.1 | 0.4 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.1 | 0.6 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.1 | 2.2 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.1 | 0.5 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.1 | 1.1 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.1 | 0.3 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.1 | 0.4 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.1 | 3.9 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.1 | 0.1 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.1 | 0.8 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.1 | 0.3 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 0.6 | PID IFNG PATHWAY | IFN-gamma pathway |
0.1 | 0.4 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.1 | 1.1 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.1 | 1.7 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.1 | 0.9 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.1 | 0.5 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.1 | 14.9 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.1 | 1.2 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.1 | 1.2 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.1 | 1.6 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.1 | 11.5 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 0.1 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.1 | 0.6 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.0 | 0.1 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.0 | 0.0 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.0 | 0.2 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.0 | 0.6 | PID BCR 5PATHWAY | BCR signaling pathway |
0.0 | 0.4 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.0 | 0.2 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.0 | 0.4 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.0 | 0.9 | PID AURORA B PATHWAY | Aurora B signaling |
0.0 | 0.2 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.0 | 0.2 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.0 | 0.0 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.0 | 0.1 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.0 | 0.1 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.0 | 0.6 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.0 | 0.1 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.0 | 0.1 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.0 | 0.2 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.0 | 0.2 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.0 | 0.1 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.0 | 0.0 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 31.9 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.8 | 14.4 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.5 | 7.6 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.5 | 5.5 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.5 | 10.1 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.5 | 5.4 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.4 | 1.5 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.4 | 2.6 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.4 | 4.8 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.4 | 3.6 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.4 | 3.2 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.3 | 2.8 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.3 | 3.7 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.3 | 35.5 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.3 | 2.7 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.3 | 3.3 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.3 | 17.6 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.3 | 6.8 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.3 | 9.4 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.3 | 3.3 | REACTOME G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA | Genes involved in G beta:gamma signalling through PI3Kgamma |
0.3 | 2.3 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.3 | 3.4 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.3 | 3.1 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.3 | 4.4 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.3 | 0.3 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.3 | 2.7 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.3 | 1.1 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.3 | 2.7 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.3 | 4.7 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.3 | 2.1 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.3 | 2.8 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.3 | 3.0 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.2 | 3.7 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.2 | 2.0 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.2 | 2.7 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.2 | 4.3 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.2 | 1.4 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.2 | 0.9 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.2 | 1.4 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.2 | 0.9 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.2 | 1.9 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.2 | 1.9 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.2 | 2.7 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.2 | 0.8 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.2 | 0.8 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.2 | 1.8 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.2 | 3.2 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.2 | 1.4 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.2 | 1.5 | REACTOME OPSINS | Genes involved in Opsins |
0.2 | 6.7 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.2 | 5.3 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.2 | 0.2 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.2 | 2.5 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.2 | 7.2 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.2 | 1.5 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.2 | 2.8 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.2 | 1.5 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.2 | 3.6 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.2 | 4.1 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.2 | 1.8 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.2 | 0.5 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.2 | 6.5 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.2 | 0.8 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.2 | 0.8 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.2 | 1.4 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.1 | 3.0 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.1 | 2.5 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.1 | 1.8 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.1 | 0.3 | REACTOME REGULATION OF INSULIN SECRETION | Genes involved in Regulation of Insulin Secretion |
0.1 | 1.1 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
0.1 | 0.4 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.1 | 1.4 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.1 | 0.7 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.1 | 1.1 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.1 | 0.9 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.1 | 0.9 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.1 | 1.4 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.1 | 1.7 | REACTOME GRB2 EVENTS IN ERBB2 SIGNALING | Genes involved in GRB2 events in ERBB2 signaling |
0.1 | 0.3 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
0.1 | 0.1 | REACTOME PI3K EVENTS IN ERBB2 SIGNALING | Genes involved in PI3K events in ERBB2 signaling |
0.1 | 1.3 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.1 | 2.4 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.1 | 3.0 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.1 | 0.1 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.1 | 0.9 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.1 | 1.3 | REACTOME SIGNALING BY FGFR MUTANTS | Genes involved in Signaling by FGFR mutants |
0.1 | 0.5 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.1 | 0.5 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.1 | 6.2 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.1 | 1.0 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.1 | 1.1 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.1 | 0.8 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
0.1 | 0.5 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.1 | 8.5 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
0.1 | 0.7 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.1 | 2.6 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.1 | 0.7 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.1 | 0.8 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.1 | 1.7 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.1 | 1.5 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.1 | 2.2 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.1 | 0.7 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.1 | 1.1 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.1 | 3.1 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
0.1 | 0.9 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.1 | 0.6 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.1 | 0.7 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.1 | 1.0 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.1 | 2.7 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.1 | 1.1 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.1 | 0.4 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.1 | 1.2 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.1 | 0.7 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.1 | 1.2 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.1 | 0.5 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.1 | 1.3 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.0 | 0.1 | REACTOME DOWNSTREAM SIGNALING OF ACTIVATED FGFR | Genes involved in Downstream signaling of activated FGFR |
0.0 | 0.1 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.0 | 1.2 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.0 | 0.1 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.0 | 0.6 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.0 | 0.8 | REACTOME ACYL CHAIN REMODELLING OF PE | Genes involved in Acyl chain remodelling of PE |
0.0 | 0.2 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.0 | 0.2 | REACTOME INTEGRATION OF ENERGY METABOLISM | Genes involved in Integration of energy metabolism |
0.0 | 0.4 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.0 | 0.9 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.0 | 0.0 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.0 | 0.1 | REACTOME NEGATIVE REGULATION OF FGFR SIGNALING | Genes involved in Negative regulation of FGFR signaling |
0.0 | 0.1 | REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | Genes involved in Regulation of Glucokinase by Glucokinase Regulatory Protein |
0.0 | 0.5 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.0 | 0.7 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.0 | 0.1 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.0 | 0.1 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.0 | 0.1 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.0 | 0.1 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.0 | 0.1 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.0 | 0.2 | REACTOME ACETYLCHOLINE BINDING AND DOWNSTREAM EVENTS | Genes involved in Acetylcholine Binding And Downstream Events |
0.0 | 0.0 | REACTOME CDK MEDIATED PHOSPHORYLATION AND REMOVAL OF CDC6 | Genes involved in CDK-mediated phosphorylation and removal of Cdc6 |
0.0 | 0.2 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.0 | 0.3 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.0 | 0.3 | REACTOME G1 PHASE | Genes involved in G1 Phase |